dreamcatcher
- 26 Sep 2012 20:57
We help our clients and their customers successfully deploy,
protect, maintain, retire and re-use technology.
The world is witnessing explosive growth in the number of connected devices, and in the power and complexity of mobile computing platforms. This is resulting in an increasing need for sophisticated technology- and user support. Regenersis addresses those needs with a growing portfolio of software-rich services building on a strong heritage of repair operations, customer service and data erasure management.
By combining our capabilities in innovative ways, tailored to individual client requirements, we deliver unique service propositions that reinforce trust in our client’s brands and create value for our business partners and shareholders.
Technology Life Cycle Services
Our international network of repair centres provides product repair, refurbishment, parts management and logistics services for mobile, IT, home entertainment and B2B infrastructure product vendors; and their sales channels, insurers, and end users. Our technically-advanced repair capabilities enjoy a solid reputation with our TMT sector clients, combining service excellence with continuous gains in cost efficiency.
Our industry-leading fault diagnostics and issue resolution technologies include the In-Field Tester for set top boxes, and our SmartChk applications suite for smartphones. These advanced diagnostic platforms improve consumer satisfaction with their devices and materially reduce the incidence and cost of product returns for our clients.
In partnership with leading insurers, our Digital Care operations deliver innovative product insurance and extended warranty programmes for our clients, protecting customers’ investments in mobile technology products.
Our Recommerce division helps manufacturers and retailers to launch products and attract new customers through upgrade and buy-back programmes.
Blancco is the global leader in data erasure management (DEM). Blancco software provides comprehensive data erasure for every type of electronic and magnetic storage media, ranging from portable flash drives and mobile phone memory to solid state drives, networked storage, virtual drives and cloud storage. Blancco DEM is a vital part of any organisation’s security infrastructure, underpinning robust data retention policies and ensuring compliance with international data protection regulations.
Regenersis around the world
Our clients increasingly seek partners who can deliver cost-effective and innovative technology life cycle services on a global basis. Since 2011, Regenersis has expanded its geographical footprint from five countries to 16. With the acquisition of Blancco in April 2014, this increased to 22 countries.
http://www.regenersis.com/about-us

Final Results
http://www.moneyam.com/action/news/showArticle?id=4451090
Financial Highlights
·
Group revenue increased by 13% to £139.9 million (2011: £123.8 million)
·
Headline operating profit(*) increased by 24% to £7.8 million (2011: £6.3 million)
·
Operating cash flow improved to £4.9 million (2011: £2.4 million).
·
Further Improvement in headline operating margin to 5.5% (2011: 5.1%)
·
Net debt reduced to £2.9 million (2011: £3.8 million)
·
Banking facility extended from £15 million to £23.25 million for the period to October 2015, to support further organic investment and incremental M&A activity
·
First dividend payment since 2007 - recommended final dividend of 1.1 pence per ordinary share
dreamcatcher
- 26 Sep 2012 21:18
- 2 of 183
Regenersis eyes expansion opportunities
Tue 25 Sep 2012
RGS - Regenersis
LONDON (SHARECAST) - Consumer electronics repair specialist Regenersis rose after it reported strong figures and was bullish in its outlook.
Group revenue rose by 13% to £139.9m in the year to the end of June, with operating profit up 24% to £7.8m.
The firm now intends to recommence paying a dividend to shareholders, announcing a final dividend of 1.1p per ordinary share to be paid n December.
It added that the company was trading in line with market expectations and opportunities for global growth, both organically and by acquisition, remained good.
"Our markets and specific client contracts continue to show growth and present regular opportunities to win significant new business," said Chairman Matthew Peacock.
"The board continues to target double digit revenue growth on steadily improving operating profit margins and, given good return on capital employed, expects to continue its R&D and capital expenditure programme."
Shares were up over 10% at 1030 on Tuesday.
dreamcatcher
- 26 Sep 2012 21:25
- 3 of 183
Regenersis CFO buys stake as firm unveils strong results
Wed 26 Sep 2012
LONDON (SHARECAST) - Jog Dhody, the Chief Financial Officer of Regenersis, a consumer electronics repair specialist, bought a stake in the firm on Tuesday, opening his account on the same day it posted a 24 per cent rise in operating profits.
Dhogy, who joined the board in March of this year, purchased 155,987 shares - his only stake in the company - at 101.50p each, costing him a total of £158,327.
On Tuesday the group said revenue rose by 13% to £139.9m in the year to the end of June, with operating profit up 24% to £7.8m.
It now intends to recommence paying a dividend to shareholders, announcing a final dividend of 1.1p per ordinary share to be paid in December.
The firm added that the company was trading in line with market expectations and said opportunities for global growth, both organically and by acquisition, remained good.
The company's share price has rise over 40% in the past year, equal to around 32p.
dreamcatcher
- 29 Sep 2012 13:48
- 4 of 183
A buy rec in this weeks IC . A promise of double digit revenue growth and steady
improving margins came good, driving underlying operating profit up 24% to £7.8m.
Cost-cutting in the uk and some big contract wins in Germany powered profits in Western Europe up 38 per cent to £2.1m. And the company's set-top-box advanced solutions division made £2.9m of profits compared with just £700,000 in the first half.
That business will get a shot in the arm from a new higher -margin pay-per-click deal with Virgin Media. Income from a similar deal with one of the big US cable tv companies
could be '' very considerable'' next year. The performance of the emerging markets operations was disappointing. The 10 per cent fall in profits was mainly due to problems at one large customer, but HDM, bought in July, brings access to customers
such as Telefonica, Nokia, and Samsung. Arden partners expects current year adjustment EPS of 15.6p (13.9p in 2012)
The future looks good for Regenersis. Yet, dispite surging 40 per cent since Oct 2011, the shares still only trade on seven times forecast earnings.
js8106455
- 01 Oct 2012 10:21
- 5 of 183
Interview with Matthew Peacock, Executive Chairman of Regenersis Plc.
Click the link to listen;
http://www.brrmedia.co.uk/event/104637/matthew-peacock-executive-chairman
dreamcatcher
- 05 Oct 2012 21:48
- 6 of 183
dreamcatcher
- 29 Oct 2012 17:14
- 7 of 183
Regenersis wins more work from Samsung
StockMarketWire.com
Regenersis (AIM: RGS), a strategic outsourcing partner to many of the world's leading consumer technology companies, has announced that it has extended its relationship with Samsung, having been selected as one of the manufacturer's strategic partners on a range of after-sales support services in the UK.
The company already supports Samsung in Poland and, following the acquisition of HDM in July 2012, also provides services to the manufacturer in Mexico and Spain.
Commenting on this latest deal, which follows a number of smaller contract wins in emerging markets over the last few weeks, Matthew Peacock, Executive Chairman of Regenersis, said: "A key element of our growth plan is to extend our support of existing customers, growing with them and solving their problems with new services in more countries.
"The acquisition of HDM helped consolidate our relationship with Samsung and win the contract with Samsung UK. We look forward to developing the relationship with Samsung further and delivering our solutions in more new territories."
The UK contract includes the repair
dreamcatcher
- 29 Oct 2012 17:19
- 8 of 183
Regenersis supports Samsung in new territory
RNS
RNS Number : 6851P
Regenersis PLC
29 October 2012
RNS Reach - Final Draft
29 October 2012
Regenersis plc
("Regenersis" or "the Group")
Regenersis supports Samsung in new territory
Regenersis (AIM: RGS), a strategic outsourcing partner to many of the world's leading consumer technology companies, is pleased to announce that it has extended its relationship with Samsung, having been selected as one of the manufacturer's strategic partners on a range of after-sales support services in the UK.
Regenersis already supports Samsung in Poland and, following the acquisition of HDM in July 2012, also provides services to the manufacturer in Mexico and Spain.
Commenting on this latest deal, which follows a number of smaller contract wins in Emerging Markets over the last few weeks, Matthew Peacock, Executive Chairman of Regenersis, said: "A key element of our growth plan is to extend our support of existing customers, growing with them and solving their problems with new services in more countries. The acquisition of HDM helped consolidate our relationship with Samsung and win the contract with Samsung UK. We look forward to developing the relationship with Samsung further and delivering our solutions in more new territories."
dreamcatcher
- 02 Nov 2012 13:48
- 9 of 183
Regenersis : Panmure Gordon keeps buy rating and 159p target.
dreamcatcher
- 03 Nov 2012 08:52
- 10 of 183
ex divi 9th Nov - divi - 1.1p payed on 5th Dec
dreamcatcher
- 06 Nov 2012 15:25
- 11 of 183
Good buying today, 4-1
dreamcatcher
- 06 Nov 2012 18:03
- 12 of 183
Ended the day up 5.67%
dreamcatcher
- 11 Jan 2013 15:16
- 13 of 183
up 5.50 % today
skinny
- 11 Jan 2013 15:17
- 14 of 183
Another excellent find DC!
dreamcatcher
- 11 Jan 2013 15:18
- 15 of 183
:-))
dreamcatcher
- 14 Jan 2013 15:34
- 16 of 183
On the up again
dreamcatcher
- 15 Jan 2013 07:08
- 17 of 183
Notice of Results and Trading Update
RNS
RNS Number : 5054V
Regenersis PLC
15 January 2013
15 January 2013
REGENERSIS PLC
NOTICE OF RESULTS AND TRADING UPDATE
Regenersis plc ("Regenersis") issues this trading update in advance of its results for the six months to 31 December 2012, which will be announced on Thursday, 14 March 2013.
The board is pleased to confirm that earnings for the half year will be in line with market expectations, following a strong trading period which has delivered further double digit organic sales growth, as well as a positive contribution from the group's recent acquisition, HDM. The Advanced Solutions division has produced very significant earnings growth and the first contribution from royalties of our In Field Tester ("IFT") in both the UK and the USA was secured. Cash flow has again been better than market expectations for the group as a whole.
The group has continued to make operating and capital expenditure investments in the development of the new service lines during the first half of the year. At the time of the Interim Results, the board expects that it will be able to provide a positive update on the progress of the IFT in the USA, as well as other initiatives. The M&A market continues to provide a number of interesting opportunities.
The group has also recently been informed that it has won a very significant, multi-geography, multi-year contract, which will contribute most to the Emerging Market Depot Solutions division. The detailed contractual terms are now in negotiation, the specifics of which will be announced with or before the group's interim results.
These developments and the half year results underpin the board's expectation for the full year, as well as adding further confidence to its expectations for good growth next financial year.
dreamcatcher
- 15 Jan 2013 13:36
- 18 of 183
Strong purchasing
dreamcatcher
- 15 Jan 2013 16:04
- 19 of 183
Just sold half my holding, will keep the rest. Have performed fantastic since September.
dreamcatcher
- 18 Jan 2013 09:11
- 20 of 183
up nearly 4%
dreamcatcher
- 24 Jan 2013 14:12
- 21 of 183
A buy in this weeks share mag. Talk of upgrades to fuel a share rally. The company has said it has won a '' Very significant,multi-geography,multi-year contract'' which will benefit its emerging market operations. Mattew Peacock willnot reveal the identity of the client, merely saying details would be announced once contractual terms are finalised over the next few weeks or within the intrim results at the latest.
dreamcatcher
- 24 Jan 2013 14:20
- 22 of 183
Panmure Gordon is looking for £7.8 million pre-tax profit in the year to june 2013, rising to £10.2 million in 2014. These being as they say ''worst case'' going forward, given likely imminent upgrades. It has a £206p target price, implying 22% upside for the shares and this may prove conservative.
dreamcatcher
- 26 Jan 2013 19:44
- 23 of 183
Shares mag,A first half trading update last week 15 Jan gave a positive outlook for the group
but only teased with details on new and existing contracts. Most of the juicy stuff will not be revealed until the interims 14 Mar . Analysts are therefore leaving their earnings forecasts untouched for now . The half year statement should cast further light on progress in both the US and UK markets with the company In Field Tester service. Maiden revenue has been achieved ahead of schedule through contracts
with an undisclosed US cable TV provider and Virgin Media in the UK. This involves a portable testing unit for repair rngineers to identify problems,essentially a much smaller version of the unit used when set-top boxes are returned to Regenersis depots for analysis. The Us has 17 to 18 times more set top boxes than the UK and therefore significant growth potential for Regenersis.Existing earnings forecasts assume no contribution from America, therev should be another line to put in any earnings upgrades at the interims.
The HDM acquisition for 6.5 million euros in July 2012 provides exposure to Spain,Mexico and Argentina and the important relationship with Samsung Electronics.
The company has gained significant contract wins with SE.
dreamcatcher
- 08 Feb 2013 16:23
- 24 of 183
Pushing towards £2 now, await the news.
dreamcatcher
- 07 Mar 2013 21:40
- 25 of 183
results for the six months to 31 December 2012, which will be announced on Thursday, 14 March 2013.
dreamcatcher
- 14 Mar 2013 07:11
- 26 of 183
Half Yearly Report
RNS
RNS Number : 9625Z
Regenersis PLC
14 March 2013
14 March 2013
REGENERSIS PLC
INTERIM RESULTS
Regenersis plc (AIM: RGS.L) ("Regenersis" or the "Group"), a strategic outsourcing partner to many of the world's leading consumer technology companies, is pleased to announce its interim results for the six months to 31 December 2012, which show a strong financial performance and the continuing benefits of the Board's growth strategy.
Financial Highlights
•
Revenue increased by 29% to £90.2 million (2011: £69.9 million)
•
Headline operating profit (*) increased by 21% to £4.6 million (2011: £3.8 million)
•
Operating profit increased by 27% to £3.7 million (2011: £2.9 million)
•
Revenue and profit progress in all divisions, particularly strong in Advanced Solutions in which revenues rose 73% and operating profit increased 100% over prior year
•
Headline operating cash flow (*) improved to £3.8 million (2011: £2.7 million), although H2 is traditionally the stronger half for cash generation
•
Operating cash flow increased by 44% to £2.3 million (2011: £1.6 million)
•
Net debt of £7.7 million (2011: £4.1 million), despite cash payments of £5.9 million in the period in relation to acquisitions, compared with £2.9 million net debt at the year end
•
Interim dividend of 0.67 pence per Ordinary Share, demonstrating the Board's commitment to a progressive new dividend policy as announced in the final results
•
Adjusted EPS up 18% to 7.96p (2011: 6.76p) and basic EPS up 16% to 5.88p (2011: 5.08p)
Operational Highlights
•
In-Field Tester (IFT) units rolled out to Virgin Media and royalty revenues commenced December 2012. Recurring royalty revenues expected from the US during H2 of the current year; prospects and sales activities are developing well.
•
In order to capitalise on these and other US opportunities the group has centred its sales and marketing operations in the US with the senior hiring of Bryce Boothby as Group Sales and Marketing Director and President of US. He also has an acquisition based remit.
•
Strong organic sales growth continues - up 17% on the same period last year, as a result of sales team performance and larger business opportunities.
•
HDM, the business acquired in July 2012, continues to perform well and in line with the Board's expectations.
Outlook
•
Current trading is in line with market expectations for the year ending 30 June 2013.
•
Opportunities for global growth both organically and by acquisition remain strong. Some of these new developments should emerge shortly. The pace of progress is expected to be sustained, as the senior management team continues to strengthen.
•
Growth in profits in 2014 is expected from the strategically important divisions of Emerging Markets and Advanced Solutions. Growth in Advanced Solutions is again expected to be significant.
Matthew Peacock, Executive Chairman of Regenersis, said: "The strategy and financial plan are established and working well. Our focus is extending our geographic reach, filling out our operating matrix (*), deepening our strategic relationships with major clients and continuing to innovate and roll out margin enhancing services."
(*) Headline operating profit excludes exceptional restructuring costs, exceptional deal costs, amortisation and impairment of acquired intangible assets and share-based payments.
(*) Headline operating cash flow excludes exceptional deal costs.
(*) The operating matrix is shown on the Regenersis website www.regenersis.com.
dreamcatcher
- 14 Mar 2013 12:23
- 27 of 183
Regenersis: Panmure Gordon takes target price from 206p to 240p and reiterates its buy recommendation
dreamcatcher
- 15 Mar 2013 21:32
- 28 of 183
Regenersis PLC (RGS:LSE) set a new 52-week high during today's trading session when it reached 200.00. Over this period, the share price is up 123.03%.
As of Mar 15, 2013, the consensus forecast amongst 2 polled investment analysts covering Regenersis PLC advises investors to purchase equity in the company
dreamcatcher
- 19 Mar 2013 16:45
- 29 of 183
Regenersis PLC (RGS:LSE) set a new 52-week high during today's trading session when it reached 204.00. Over this period, the share price is up 124.72%.
dreamcatcher
- 20 Mar 2013 18:06
- 30 of 183
Regenersis PLC (RGS:LSE) set a new 52-week high during today's trading session when it reached 210.00. Over this period, the share price is up 133.71%.
dreamcatcher
- 21 Mar 2013 17:30
- 31 of 183
A buy in this weeks Shares mag - Regenersis starts biggest -ever contract.
Patient investors should hold their nerve even though Regenersis half year results 14 Mar do not provide any news on its biggest ever contract win. Having flagged up its success on 15 Jan , the set top box -to- mobile phone repair specialist had been expected to reveal details at the interims, yet it merely said the terms were stillm being negotiated. Shares has learned the 'multi - geographical' contract has actually started and the lack of news in the interims was down to lengthy paperwork after a decision to structure the deal as a global agreement.The contract is with a large Asian manufacturer with work initially focused on Romania, Poland and Spain.
dreamcatcher
- 28 Mar 2013 07:16
- 32 of 183
dreamcatcher
- 28 Mar 2013 07:17
- 33 of 183
dreamcatcher
- 01 Apr 2013 20:20
- 34 of 183
As of Mar 29, 2013, the consensus forecast amongst 2 polled investment analysts covering Regenersis PLC advises investors to purchase equity in the company.
dreamcatcher
- 19 Apr 2013 07:05
- 35 of 183
Acquisition
RNS
RNS Number : 7341C
Regenersis PLC
19 April 2013
19 April 2013
Regenersis plc
Acquisition of the largest independent set top box repair business in South Africa
Regenersis plc (AIM: "RGS") ("Regenersis" or the "Group"), a strategic outsourcing partner to many of the world's leading consumer technology companies, is pleased to announce that it has agreed to acquire all of the issued share capital of Landela Electronics (Proprietary) Ltd ("Landela") for a consideration of 21.2m ZAR (£1.5 million) on a cash-and debt-free basis. The effective date of exchange was 18 April 2013 and completion is anticipated to occur on 25 April 2013.
Acquisition highlights:
· Landela is the largest set top box repair business in South Africa, which operates from two facilities in Johannesburg and East London.
· Landela's key customers are dominant in the provision of satellite TV to the South African market and 11 other countries in Africa, with a market share in excess of 90%.
· Market penetration in South Africa of satellite TV is less than 28% of the total population, presenting very significant growth opportunities.
· Growth in the satellite TV subscriber base in South Africa has been in double digits in each of the previous three years and is expected to accelerate.
Regenersis anticipates that, in the year to 30 June 2014, Landela will be earnings enhancing. Regenersis also anticipates that it will be able to service this growing new market with its proprietary IFT diagnostic technology, creating efficiencies and financial savings for its clients, whilst further building the business in this growth market. Landela's customers operate on a pan-African basis and this will provide a platform for growth throughout the continent.
The current senior management team, which owned the shares of Landela, will remain with the business for a short transition period.
The acquisition of Landela will enhance the progress already made organically by the Group in the South Africa market; it will bring an additional service line into South Africa; it will provide opportunities to grow into other adjacent countries and enable a further route to market for the Group's patented IFT technology.
Matthew Peacock, Executive Chairman of Regenersis, said: "As a bolt-on deal, this acquisition fits the profile of what we are trying to do very well and we are pleased to announce it so soon after a successful fundraising. Regenersis is looking for acquisitions which add at least one of the following to the Group's portfolio: a new client(s), geography or technology, as well as being accretive. Landela delivers a market leading position in set top box service provision, in this important geography, further filling out our operating matrix."
dreamcatcher
- 25 Apr 2013 09:08
- 36 of 183
As of Apr 20, 2013, the consensus forecast amongst 2 polled investment analysts covering Regenersis PLC advises investors to purchase equity in the company.
dreamcatcher
- 26 Apr 2013 15:34
- 37 of 183
Directorate Change
RNS
RNS Number : 3242D
Regenersis PLC
26 April 2013
26 April 2013
Regenersis plc
Directorate Change
Regenersis plc (AIM: "RGS") ("Regenersis" or the "Company"), a strategic outsourcing partner to many of the world's leading consumer technology companies, announces that Kevin Bradshaw, non-executive director, has resigned from the Company with immediate effect to concentrate on his new role as Chief Executive of Garden Centre Group.
It is the Board's intention to appoint a replacement non executive director, following an orderly recruitment process.
Matthew Peacock, Executive Chairman of Regenersis, said: "On behalf of the Board, I would like to thank Kevin for his considerable contribution over the last year."
dreamcatcher
- 29 Apr 2013 18:35
- 38 of 183
Regenersis PLC (RGS:LSE) set a new 52-week high during today's trading session when it reached 222.00. Over this period, the share price is up 120.60%.
As of Apr 26, 2013, the consensus forecast amongst 2 polled investment analysts covering Regenersis PLC advises investors to purchase equity in the company
dreamcatcher
- 01 May 2013 19:21
- 39 of 183
Regenersis PLC (RGS:LSE) set a new 52-week high during today's trading session when it reached 224.00. Over this period, the share price is up 122.50%.
dreamcatcher
- 03 May 2013 15:55
- 40 of 183
ex divi 8 May 0.67p payment on 7 June
dreamcatcher
- 03 May 2013 22:30
- 41 of 183
In The week mag this week - Directors dealings , CFO Jog Dhody and chairman Matthew Peacock bought into recent weekness. (61,000 shares ) Dhody's purchases have a history of sparkling rallies.
dreamcatcher
- 08 May 2013 20:21
- 42 of 183
Regenersis PLC (RGS:LSE) set a new 52-week high during today's trading session when it reached 228.00. Over this period, the share price is up 123.27%
dreamcatcher
- 14 May 2013 18:44
- 43 of 183
Regenersis PLC (RGS:LSE) set a new 52-week high during today's trading session when it reached 230.00. Over this period, the share price is up 140.00%.As of May 10, 2013, the consensus forecast amongst 2 polled investment analysts covering Regenersis PLC advises investors to purchase equity in the company.
dreamcatcher
- 08 Jul 2013 16:11
- 44 of 183
Strategic Update - New Business Unit Established
RNS
RNS Number : 7560I
Regenersis PLC
08 July 2013
Strategic update - New Advanced Solutions business unit established
Regenersis plc (AIM: "RGS") ("Regenersis" or the "Group"), a strategic outsourcing partner to many of the world's leading consumer technology companies, is pleased to announce the formation of a new business unit within its Advanced Solutions Division and the formation of a related Joint Venture company.
The new business unit, called Renew, brings together the Group's Recommerce, Refurbishment and Digitalcare activities for the first time. The formation of Renew follows the Group's strategy to identify and deliver innovative, higher margin products and services in the after-market service sector for mobile devices, which offer cost effective solutions and revenue generating opportunities for Regenersis' customers, including insurance companies, network operators and retailers.
Fully refurbished devices are increasingly being bundled with warranty extension services and insurance; Renew will, amongst other things, provide legitimate, quality refurbished devices to the end customer, as well as logistics and consultancy services - a new range of activity for Regenersis.
In the last few weeks, Renew has won several new contracts with significant new activities for Telefonica in Spain; other clients in Poland, as well as the Phonehouse, Telefinance and Solid in Sweden.
Regenersis has appointed a senior industry MD to manage and direct Renew, who will join the Regenersis Executive Board on assumption of his role.
Regenersis Refurbishment Ltd, a joint venture company owned 51% by Regenersis and 49% by Ecoasia Technologies Ltd, is being established to exploit Refurbishment opportunities in Mainland Europe across Regenersis' client base and manage global Refurbishment programs for OEMs. Ecoasia is a market leading firm in Refurbishment capabilities with facilities in Manila, Hong Kong, China and Mexico.
Matthew Peacock, Executive Chairman of Regenersis, said: "It is encouraging to see how quickly the Renew activities have grown from what were just plans a year or so ago. Renew is a clear demonstration of our ability to deliver new organic growth opportunities which, we believe, will allow us to maintain an impressive growth record."
dreamcatcher
- 10 Jul 2013 07:05
- 45 of 183
Notice of Results and Trading Update
RNS
RNS Number : 9535I
Regenersis PLC
10 July 2013
REGENERSIS PLC
Notice of results and trading update
Regenersis plc (AIM: RGS) ("Regenersis" or "the Group"), a strategic outsourcing partner to many of the world's leading consumer technology companies, issues this trading update in advance of its results for the year ended 30 June 2013, which will be announced on Tuesday, 24 September 2013.
Trading
Trading for the year ended 30 June 2013 will be in line with market expectations. This follows a strong trading period which has delivered further double digit organic sales growth, as well as a positive contribution from the Group's recent acquisitions, despite foreign exchange head winds on the translation of overseas earnings.
Cash flow management during the course of the full year has further improved with net debt at 30 June 2013 being substantially better than market estimates. This strong financial performance has delivered a year-end balance sheet that is well placed to support further organic and acquisitive growth.
Both Emerging Markets and Advanced Solutions are showing particularly good earnings growth for the period with Emerging Markets delivering a return to earnings growth at an even stronger growth rate than the group as a whole. The Advanced Solutions division is also delivering growth at nearly twice the rate of the prior period, despite funding start-up losses in Digitalcare. In the second half, the division also benefited from its first full period of In Field Tester ("IFT") royalty contributions in the UK.
Managing Director of Renew
Further to the announcement made on 8 July 2013, Pritpal Matharu has been appointed as the MD of our new Advanced Solutions business unit, Renew, and as a member of the Regenersis Executive Board. He will join the Group shortly from Carphone Warehouse PLC, where he has spent the last four years building the B2B Services division, including leading the Business Development, Operations and Account Management functions. Prior to this, he spent 13 years at the electrical chain Comet in senior roles within Supply Chain, eCommerce and After Sales Services.
Matthew Peacock, Executive Chairman of Regenersis, said:
"Our strategy, to deliver double digit sales and earnings growth, by concentrating on Emerging Markets and Advanced Solutions, continues to work well. The acquisitions we completed during the year in Latin America and South Africa, along with the recently announced Renew initiative in Advanced Solutions, also have significant growth potential.
"We are pleased to welcome Pritpal to the Group and look forward to working with him on Renew. Pritpal is part of a planned investment in senior people that Regenersis will be making over the next few months to manage the business through the next two to three years of growth.
"Our ongoing strategic development, investment in senior people and continuing good results underpin the Board's expectation for further double digit growth next financial year and beyond."
dreamcatcher
- 09 Sep 2013 17:33
- 46 of 183
Strong purchasing today.
REGENERSIS PLC
Notice of results and trading update
Regenersis plc (AIM: RGS) ("Regenersis" or "the Group"), a strategic outsourcing partner to many of the world's leading consumer technology companies, issues this trading update in advance of its results for the year ended 30 June 2013, which will be announced on Tuesday, 24 September 2013.
dreamcatcher
- 11 Sep 2013 16:11
- 47 of 183
A goods week for RGS so far.
As of last trade Regenersis PLC (RGS:LSE) traded at 237.00, 2.16% below its 52-week high of 232.00, set on May 15, 2013.
goldfinger
- 11 Sep 2013 16:18
- 48 of 183
Breakout DC.
dreamcatcher
- 11 Sep 2013 16:24
- 49 of 183
:-))
dreamcatcher
- 13 Sep 2013 16:12
- 50 of 183
Regenersis PLC (RGS:LSE) set a new 52-week high during today's trading session when it reached 238.00. Over this period, the share price is up 165.92%.
dreamcatcher
- 19 Sep 2013 16:02
- 51 of 183
Shares - electronic goods repair specialist Regenersis should grab the markets attention with next weeks finals. 24 Sept . The market will embrace confirmation of strong cashflows and a reiteration of the opportunities enjoyed by the firm in the US and emerging markets. The £117m illion market cap is forecast to produce £8.4m pre-tax profit and declare a 2p dividend that puts the stock on a 0.9% prospective yield. There is scope for significant increases. The shares look cheap amid potential for further earnings upgrades as new territories are established.
goldfinger
- 19 Sep 2013 17:25
- 52 of 183
Thanks for sharing DC.
Been a good day for this one.......nice.
Remind me to put a Finals collective Brokers forecasts for results. On laptop at moment so cant post it as its a premium back door site I have saved on the PC network at other end of house.
dreamcatcher
- 19 Sep 2013 17:41
- 53 of 183
do that goldfinger. Another company going places
goldfinger
- 19 Sep 2013 17:44
- 54 of 183
Will do cheers. hemscott premium not that Digital look one which is usually a few days out of date.
Ill send you the URL, think it costs about £325 per annum normally. I just swiped it of the Fool Site and its been ok for last 5 years. Pretty good for research and hyping stock.
dreamcatcher
- 19 Sep 2013 20:45
- 55 of 183
Shares - The market has yet to latch onto Augusts news that Regenersis acquired a 52.6% stake in Indian repair group Digicomp, probably because the deal was announced by the vendor Allied Digital. Regenersis has gone on to acquire a further 27% of the business from other shareholders and is expected to flag the deal next week. Digicomp provides exposure to 22 cities and more than 100 locations through a network of customer walk-in centres and depot repair facilities, working for brands including Dell, Asus, Acer. Microsoft's purchase of Nokia's mobile phone business could be an opportunity. Nokia is a big client and it is understood that the entire service team which deals with the repair specialist has transferred to Microsoft, so there could be client relationship continuity. Microsoft is also expected to invest in the mobile phone business, so sales volumes could increase which in turn implies more phones for Regenersis to test and fix.
goldfinger
- 23 Sep 2013 08:55
- 56 of 183
Regenersis PLC
REGENERIS
FORECASTS
2013 2014
Date Rec Pre-tax (£) EPS (p) DPS (p) Pre-tax (£) EPS (p) DPS (p)
Arden Partners
20-09-13 BUY 8.26 15.63 2.00 10.49 18.37 2.40
Panmure Gordon
20-09-13 BUY 8.47 15.80 2.00 10.60 18.40 2.20
Equity Development
18-03-13 None 7.49 14.99 2.00 9.74 19.04 2.50
2013 2014
Pre-tax (£) EPS (p) DPS (p) Pre-tax (£) EPS (p) DPS (p)
Consensus 8.38 15.72 2.00 10.55 18.39 2.29
1 Month Change -0.00 -0.00 0.00 -0.00 0.00 0.00
3 Month Change -0.00 0.01 0.00 -0.14 -0.10 -0.11
GROWTH
2012 (A) 2013 (E) 2014 (E)
Norm. EPS 17.07% 40.24% 16.93%
DPS % % 14.40%
INVESTMENT RATIOS
2012 (A) 2013 (E) 2014 (E)
EBITDA £5.78m £10.39m £12.63m
EBIT £4.24m £m £m
Dividend Yield 0.00% 0.81% 0.93%
Dividend Cover x 7.86x 8.04x
PER 21.98x 15.68x 13.41x
PEG 1.29f 0.39f 0.79f
Net Asset Value PS 5.27p p p
goldfinger
- 24 Sep 2013 00:56
- 57 of 183
Results in the morning.
Fingers crossed etc etc.
dreamcatcher
- 24 Sep 2013 07:05
- 58 of 183
Preliminary Results
RNS
RNS Number : 6993O
Regenersis PLC
24 September 2013
24 September 2013
Regenersis Plc
(AIM: "RGS")
Preliminary results for the year ended 30 June 2013
Regenersis Plc ("Regenersis" the "Company" or the "Group"), a strategic outsourcing partner to many of the world's leading consumer technology companies, is pleased to announce its preliminary results for the year ended 30 June 2013, which show a strong financial performance and good growth, along with a number of positive corporate developments including acquisitions after the year end.
Highlights
· Good growth at increasing rates whilst doubling operating cash flow and reducing net debt.
· Dividend increased substantially.
· Two strategic acquisitions in Emerging Markets, an important partnership for Refurbishment and the expansion of remote diagnostics interests into mobile.
· Major step-up in new business wins in H2 which has continued after the year end.
· 81% of the Group's headline operating profit generated from the strategically important Emerging Markets and Advanced Solutions Divisions.
· Three 'game changers' identified for the next 2-3 years, which underpin the growth strategy in Emerging Markets and Advanced Solutions - quality of our people, globalisation of our business on a matrix of countries and services and M&A.
Financial Highlights
· Group revenue increased to £179.7 million (2012: £139.9 million) - up 28%.
· Headline operating profit* increased to £9.5 million (2012: £7.8 million) - up 22%.
· Operating profit more than doubled to £7.1 million (2012: £2.1 million).
· Adjusted EPS increased by 21% to 16.80p (2012: 13.85p) and basic EPS increased by 216% to 10.53p (2012: 3.33p).
· Headline operating cash flow** increased to £11.0 million (2012: £5.9 million) - up 86%.
· Operating cash flow more than doubled to £9.9 million (2012: £4.9 million).
· Capital expenditure and R&D increased to £4.2 million (2012: £3.3 million) - up 27%.
· Successful placing to raise £6.9 million in March 2013 which has been used to support organic growth and acquisitions.
· Net debt reduced to £1.9 million (FY 2012: £2.9 million and HY 2013: £7.7 million).
· Recommended final dividend of 1.83 pence per ordinary share (2012: 1.1 pence per share), giving a total dividend for the year of 2.5 pence per ordinary share (2012: 1.1 pence) - up 127%.
(*) Headline operating profit excludes acquisition costs, exceptional restructuring costs, amortisation and impairment of acquired intangible assets, share-based payments, and share of jointly controlled entities.
(**) Headline operating cash flow excludes tax and interest payments.
Operating Highlights
· Management scaled for growth: new senior team appointed.
· Successful integration of the HDM Group of Companies ("HDM"), achieving contract wins by combining new local capabilities with the Regenersis brand and global sales force.
· Implementation of a new global sales force across APAC, EMEA and Americas.
· Renew division established within Advanced Solutions, bringing together Recommerce, Refurbishment and Digital Care.
· Major new business wins in H2, with several landmark multiyear contracts including:
o becoming the Europe-wide mobile repair provider for a major OEM;
o device refurbishment and supply partner for Telefonica Insurance;
o packaged insurance (Digital Care) and Recommerce solution for market-leading Polish mobile operator;
o New contracts in South Africa, Sweden, Mexico and Romania.
· Global presence extended to include India, serving our goal to grow in Emerging Markets.
· Results delivered in spite of the significant reduction in volume from certain of our largest clients, who experienced volume shrinkage in their end markets.
· 81% of the Group's headline operating profit generated from the strategically important Emerging Markets and Advanced Solutions Divisions.
M&A Highlights
· Landela Electronics (Proprietary) Ltd ("Landela") acquired on 25 April 2013 for 21.2m ZAR (£1.5 million) - largest set top box repair business in South Africa, bringing a significant new customer to the Group.
· New partnership with EcoAsia Technologies Ltd ("EcoAsia") formed in July 2013 to fulfil refurbishment opportunities across Regenersis' client base in mainland Europe and manage global refurbishment programmes for OEMs.
· Digicomp Complete Solutions Limited ("Digicomp") acquired on 10 September 2013 for INR 451 million (£4.4 million), giving Regenersis significant presence in Indian aftermarket services business.
· Investment of USD 1.2 million (£0.75 million) in Xcaliber Technologies LLC and Xcaliber Infotech PVT Ltd ("Xcaliber") on 17 September 2013, a developer of telecoms solutions primarily focused on remote diagnostics software for smartphones, adding to existing diagnostics offer both in the US and globally.
Strategy Update
· The strategy announced in June 2011 is working well. As we enter the third year of this strategy, we will continue to focus on Emerging Markets and Advanced Solutions, on expanding and populating a matrix of services and territories to exploit cross-selling opportunities, maximising return on investments and shared overheads and cumulatively increasing the competitive advantage of the Group.
· Overall the Group is focussing on three 'game changers' for the next 2-3 years, which underpin the growth strategy in Emerging Markets and Advanced Solutions. These are: quality of our people, globalisation of our business on a matrix of countries and services and M&A.
· Acquisitions and corporate developments are an important element of the strategy as the Group has now demonstrated the ability both to attract desirable targets and corporate partnerships, generate sales synergies, and provide good, earnings-accretive growth. The Group has a healthy pipeline of these opportunities.
· Organic growth in developed markets is also becoming a feature as the Group is competing successfully for much larger, multi-geography pieces of business than in prior periods, in large part due to the expanding geographical footprint and best-of-breed capabilities it is able to offer.
The strategy of organic and acquisitive growth is supported by the Group's ability to attract and retain top talent, which has become an area of significant strength and competitive advantage.
Outlook
· Current trading is in line with market expectations.
· New business wins have progressed very well and are significantly ahead of the run rate at this stage for last year.
· Opportunities for global growth, both organically and by acquisition, remain strong.
· Continuing strong growth expected from Emerging Markets and Advanced Solutions.
· In June 2011, we set out a strategy to target double digit rates of growth in revenue and profits for the following 2-3 years. We have achieved that. Having invested well, we now believe the opportunity exists to continue to grow annually at double digit rates of growth for the foreseeable future.
· Investment in capital expenditure and head office cost growth will continue throughout the business, in order to deliver efficiencies and further growth in 2015 and beyond.
Matthew Peacock, Executive Chairman of Regenersis, said: "Regenersis has delivered another strong performance: from the revenue line down to EPS growth, as well as excellent free cash flow. Consistent with our strategy set out in 2011, the opportunity exists to maintain these levels of growth for the foreseeable future. We have invested in our management team to continue the pace of progress and expect future success."
dreamcatcher
- 24 Sep 2013 07:06
- 59 of 183
Fantastic results goldfinger,
goldfinger
- 24 Sep 2013 07:50
- 60 of 183
Glorious indeed DC.
Outlook
· Current trading is in line with market expectations.
· New business wins have progressed very well and are significantly ahead of the run rate at this stage for last year.
· Opportunities for global growth, both organically and by acquisition, remain strong.
· Continuing strong growth expected from Emerging Markets and Advanced Solutions.
· In June 2011, we set out a strategy to target double digit rates of growth in revenue and profits for the following 2-3 years. We have achieved that. Having invested well, we now believe the opportunity exists to continue to grow annually at double digit rates of growth for the foreseeable future.
· Investment in capital expenditure and head office cost growth will continue throughout the business, in order to deliver efficiencies and further growth in 2015 and beyond.
Matthew Peacock, Executive Chairman of Regenersis, said: "Regenersis has delivered another strong performance: from the revenue line down to EPS growth, as well as excellent free cash flow. Consistent with our strategy set out in 2011, the opportunity exists to maintain these levels of growth for the foreseeable future. We have invested in our management team to continue the pace of progress and expect future success."
Enquiries:
Regenersis Plc +44 (0) 20 3657 7000
Matthew Peacock, Executive Chairman
goldfinger
- 24 Sep 2013 08:39
- 61 of 183
Looking good at the moment.
justposted on twitter......
Equity Development @equity_research 7m
$RGS Regenersis up (another) 2% to new all time high 248p: To join Results Webinar with Management on Thursday SEE: http://tiny.cc/zjhbo
http://www.equitydevelopment.co.uk/
goldfinger
- 24 Sep 2013 09:15
- 62 of 183
RESEARCH ALERT-Regenersis: Panmure raises price target
24 Sep 2013 - 08:35
Sept 24 (Reuters) - Regenersis PLC : * Panmure raises price target to 302p from 240p; rating buy For a summary of rating actions and price target changes on European companies
dreamcatcher
- 25 Sep 2013 16:13
- 63 of 183
The naked trader -
Some of you know I've been building a position in Regenerisis (LON:RGS) in my pension for some time and now I added some to the ISA too.
A superb report yesterday: everything is on the way up and I like the way the company talks about three potential "game changers".
dreamcatcher
- 25 Sep 2013 16:14
- 64 of 183
Regenersis PLC (RGS:LSE) set a new 52-week high during today's trading session when it reached 263.20. Over this period, the share price is up 137.12%.
goldfinger
- 25 Sep 2013 16:46
- 65 of 183
DC broker note out this afternoon....here..........
Dear Mick,
Regenersis released an excellent set of results for the year ended 30 June 2013. Revenue increased by 28% to £179.7m, headline Operating Profit rose by 22% to £9.5m, and adjusted EPS grew by 20% to 16.8p. As a sign of its confidence in the future, the full year dividend is increased by 127% to 2.5p; the Finance Director has also just purchased further shares.
In less than 3 years the Group has been transformed. It has the people, the global reach and deal-making skills to drive earnings forward and to merit a higher rating on those earnings than the current 13.7x forward PER.
Download full report here
dreamcatcher
- 25 Sep 2013 16:48
- 66 of 183
Looks good goldfinger, thanks for that.
goldfinger
- 25 Sep 2013 16:52
- 67 of 183
DC im trying to download the full note........
http://info@equitydevelopment.co.uk
goldfinger
- 25 Sep 2013 16:55
- 68 of 183
Looks like theirs a glitch. Have you got a subscription with them.
Try doing it from your end. Cant seem to open it.
dreamcatcher
- 25 Sep 2013 16:59
- 69 of 183
I just get a sign windows cannot find it ?
dreamcatcher
- 25 Sep 2013 17:00
- 70 of 183
Lol, it does say check the spelling and try again. :-))
dreamcatcher
- 25 Sep 2013 17:02
- 71 of 183
Even put an ''S'' on the end of development to no avail. lol
goldfinger
- 25 Sep 2013 17:02
- 72 of 183
Got it in my e-mail.
Might be best to go direct to the site.
Usually do a good note on companys.
dreamcatcher
- 25 Sep 2013 17:04
- 73 of 183
See if that works
dreamcatcher
- 25 Sep 2013 21:36
- 74 of 183
Regenersis CFO tops up stake as results impress
Tue, 24 September 2013
Jog Dhody, the Chief Financial Officer of Regenersis, on Tuesday acquired 39,000 ordinary shares in the outsourcing partner on the same day it posted "a strong financial performance and good growth" for the year ended June 30th.
Dhody bought the shares a price of 255p per share, spending a total of £99,450. Following the acquisition, he has a beneficial interest of 355,285 shares, representing 0.7% of the company's issued share capital.
In the 12 months to the end of June, the company's revenue increased to £179.7m (2012: £139.9m), while headline operating profit increased to £9.5m (2012: £7.8m) and pre-tax profit of £5.67m (2012: £1.68m).
Net debt fell to £1.9m (FY 2012: £2.9m and HY 2013: £7.7m).
The group recommended a final dividend of 1.83p per ordinary share (2012: 1.1p per share), giving a total dividend for the year of 2.5p per ordinary share (2012: 1.1p) - up 127%.
goldfinger
- 25 Sep 2013 21:59
- 75 of 183
Looks good for us DC.
We know are onions .......LOL.
dreamcatcher
- 25 Sep 2013 22:04
- 76 of 183
lol
dreamcatcher
- 25 Sep 2013 22:11
- 77 of 183
I put three threads together for Regenisis, Cranware and Clinigen. Got two right so far. Cranware looked promising but to date has underperformed and do not currently hold. The other two are going fantastic.
ExecLine
- 26 Sep 2013 13:41
- 78 of 183
goldfinger
- 26 Sep 2013 14:59
- 80 of 183
Cheers ExecLine appreciated.
DC .......Halifax wont be on my tail mate,Ive had him filtered for over a year.
dreamcatcher
- 26 Sep 2013 16:52
- 81 of 183
He must be costing moneyam a fortune. Investors must be walking away from this site. Always negative. Sounds like his previous employment was a school games teacher or in the army.
halifax
- 26 Sep 2013 16:59
- 82 of 183
dc or perhaps even a police officer....... behave girls!!
dreamcatcher
- 26 Sep 2013 17:00
- 83 of 183
I thought so. :-))
goldfinger
- 27 Sep 2013 08:24
- 84 of 183
DC just filter him. hes a waste of space.
dreamcatcher
- 27 Sep 2013 15:21
- 85 of 183
IC today - Regenersis charging ahead.
Chief executive Matthew Peacock is confident the group can achieve double-digit revenue and earnings growth for the next three years.
Regenersis is becoming the dominant player in the market and also boasts a strong balance sheet. They still trade on 14 times forecast earnings. That looks too modest given the potential for further growth and market share wins.
dreamcatcher
- 03 Oct 2013 17:21
- 86 of 183
A buy in this weeks Shares - Directors buying sends vote of confidence. Stock broker Panmure Gordon increased its price target from 240p to 302p on the back of the results.
dreamcatcher
- 11 Oct 2013 15:49
- 88 of 183
Any decent company seems to be holding up well in these uncertain market times.
dreamcatcher
- 15 Oct 2013 18:43
- 89 of 183
Sp climbing hard since 1 sept.
goldfinger
- 15 Oct 2013 18:46
- 90 of 183
Going well, itl do me.
dreamcatcher
- 16 Oct 2013 21:06
- 91 of 183
I see the Naked trader has a target price of 280p
dreamcatcher
- 17 Oct 2013 18:04
- 92 of 183
Four pages in this weeks Shares covering 4 directors buys and RGS being one of them. It focuses on Joc Dhody the chief financial officer. His most successful past trade was 155,987 shares purchased in Sept 12 to then go on to gain 112%. His most recent buy was 24 Sept 13 - 39,000 shares at 255p . A good signal being sent to the market. Panmure Gordon states it is the 'go to' solutions house for the industry. Cenkos says the shares could be re-valued towards 400p.
goldfinger
- 17 Oct 2013 18:11
- 93 of 183
Yep back to form today.
dreamcatcher
- 23 Oct 2013 17:29
- 94 of 183
Regenersis PLC (RGS:LSE) set a new 52-week high during Tuesday's trading session when it reached 284.00. Over this period, the share price is up 114.94%.
dreamcatcher
- 01 Nov 2013 16:04
- 95 of 183
Director/PDMR Shareholding
RNS
RNS Number : 9706R
Regenersis PLC
01 November 2013
REGENERSIS PLC
(the "Company")
Director shareholding
Regenersis plc, a strategic outsourcing partner to many of the world's leading consumer technology companies has received notification that Hanover Investors Management (Cayman) Ltd has on 31 October 2013 acquired 40,000 ordinary shares in the Company at a price of 256p per share.
Following this acquisition, Hanover Investors and its connected parties are interested in 10,826,637 shares (representing 21.8% of the issued share capital). Matthew Peacock and Tom Russell, both executive directors of the Company, have an indirect beneficial interest in the shares held by Hanover Investors through their association with Hanover Investors.
dreamcatcher
- 04 Nov 2013 16:57
- 96 of 183
Bodes well -
Director Deals - Regenersis PLC (RGS)
BFN
Rob Woodward, Non Executive Director, bought 4,459 shares in the company on the 4th November 2013 at a price of 269.52p. The Director now holds 4,459 shares.
Story provided by StockMarketWire.com
Director deals data provided by www.directorsholdings.com
dreamcatcher
- 14 Nov 2013 15:45
- 97 of 183
Regenersis PLC (RGS:LSE) set a new 52-week high during today's trading session when it reached 290.70. Over this period, the share price is up 99.79%.
dreamcatcher
- 15 Nov 2013 15:18
- 98 of 183
up another 7%
dreamcatcher
- 15 Nov 2013 17:19
- 99 of 183
IC today - Regenersis rings the right tune.
Judging by the actions of the company's board members . the shares could still have some way to go. Chairman Matthew Peacock and director Tom Russell recently purchased 40,000 shares at 256p each, totalling £102,400. Independentb non executive director Rob Woodward snapped up 4,459 at 269p on 4 Nov, which followed finance director Jog Dhody's purchase of 39,000 shares on 24 Sept at 255p.
After a significant re-rating , the shares are trading on 15 times forward earnings, but given the potential for double digit EPS growth over the next two years and the fact that the company's directors are piling into the shares, we would suggest to run profits.
dreamcatcher
- 15 Nov 2013 17:23
- 100 of 183
Closed up 9.11%
dreamcatcher
- 27 Nov 2013 20:40
- 101 of 183
Regenersis PLC (RGS:LSE) set a new 52-week high during today's trading session when it reached 327.00. Over this period, the share price is up 137.73%.
As of Nov 23, 2013, the consensus forecast amongst 3 polled investment analysts covering Regenersis PLC advises investors to purchase equity in the company
dreamcatcher
- 28 Nov 2013 15:17
- 102 of 183
Regenersis PLC (RGS:LSE) set a new 52-week high during today's trading session when it reached 345.00. Over this period, the share price is up 152.75%.
dreamcatcher
- 29 Nov 2013 22:27
- 103 of 183
Regenersis PLC (RGS:LSE) set a new 52-week high during today's trading session when it reached 360.00. Over this period, the share price is up 164.10%.
dreamcatcher
- 30 Nov 2013 08:52
- 104 of 183
Dividend Wednesday 4 Dec - 1.83p
dreamcatcher
- 07 Dec 2013 17:54
- 105 of 183
Regenersis PLC 28 November 2013
Seizing the moment in aftermarket services
Aggressive cross-selling across this continually enlarging network should
see the company emerge as a global leader in this field, particularly as it
digs deeper into emerging markets in Europe, Africa, Asia and South
America.
Management continues to be strengthened, allowing senior executives
sufficient bandwidth to execute strategy and seek new opportunities.
A best-in-class M&A team, a robust balance sheet, and access to cash, put
the company in a strong position to pursue accretive acquisitions that
expand and populate the matrix of services and territories underpinning
strategy.
The above, together with the streamlined One-Regenersis operational
execution and branding exercise, will further widen the gap between
Regenersis and the fragmented competition, who have neither the scale or
resources to invest in growth and new technologies.
We believe that the current market value does not reflect the
company’s strengths and potential. On the basis of current
conservative forecasts but an increasing rating, we derive a target
price of 406p, and see this as the next step in a future comprehensive
revaluation.
http://www.equitydevelopment.co.uk/doc/1142.pdf
dreamcatcher
- 12 Dec 2013 07:10
- 106 of 183
Increase in Total Banking Facilities
RNS
RNS Number : 3309V
Regenersis PLC
12 December 2013
12 December 2013
Regenersis Plc
(AIM: "RGS")
Increase in Total Banking Facilities
Regenersis Plc ("Regenersis" the "Company" or the "Group"), a strategic outsourcing partner to many of the world's leading consumer technology companies, is pleased to announce it has increased its total banking facilities with HSBC from £23 million to £39 million.
The key changes in the total facilities are as follows:
•
Revolving Credit facility increased from £20 million to £30 million - This will support Regenersis' growth plans both organically and through acquisitions with further access to funds. The costs of borrowing and the covenants remain unchanged.
•
A new Invoice Discounting facility of £6 million - This will give Regenersis the flexibility to accommodate the greater working capital requirements associated with its new business lines.
•
The Overdraft facility remains unchanged at £3 million.
•
The term of the facility has been extended from October 2015 to October 2016 - This gives Regenersis clear certainty of funding over the next three years.
Matthew Peacock, Executive Chairman of Regenersis, said: "We are delighted with the continued support we have received from our bankers HSBC. The increased facilities give Regenersis significant fire power to continue its strategic growth plans and investments in the Emerging Markets and Advanced Solutions divisions."
dreamcatcher
- 12 Dec 2013 16:27
- 107 of 183
Shares - This is a rare high -powered profits growth story in the support services sector. Panmure Gordon had a 206p price target, this now stands at 402p as a reflection of earnings upgrades so far in 2013 and potential for much greater earnings growth in the future.
The broker reckons there will be 'material lumps of business moving to Regenersis which others cannot even to begin to compete on'. We like the fact the boardroom executives are putting their own money into the stock, even after the shares ten fold rise since summer 2010.
Bullshare
- 17 Dec 2013 17:04
- 108 of 183
Organised in partnership with Cenkos Securities and Shares magazine, the second Innovators & Investors Forum will take place on 4th February 2014 at the Business Design Centre, London N1.
The event aims to showcase up to 40 leading innovative and imaginative technology-led firms and to bring them together with the investment community. It combines both a company expo and an educational conference where delegates learn about a range of investment opportunities.
REGISTER NOW
Why attend?
This event gives you a platform to meet under one roof up to 40 technology-led companies, hear their messages during presentation seminars and engage in discussions with them on their stands.
The event is supported with an extensive conference program, including keynote speakers and company presentations.
Companies already confirmed for the 4th February 2014 include:
Angle
Avanti Communications Group
Bond International Software
Brady
CML Microsystems
Earthport
Enables IT
Escher
Forbidden Technologies
Globo
InternetQ
KBC Advanced Technologies
Optimal Payments
Regenersis
StatPro
Transense Technologies
Ubisense
CONFERENCE AGENDA
10:45 Private Investors’ registration and coffee
11:40 Company presentation - InternetQ
11:55 Company presentation - Earthport
12:10 Company presentation - To be confirmed
12:25 Company presentation - To be confirmed
12:40 Lunch
14:00 Keynote address - Richard Penny, Senior Fund Manager - Legal & General
14:15 Russ Mould, Editor, Shares Magazine
14:30 Company presentation - To be confirmed
14:45 Company presentation - Optimal Payments
15:00 Company presentation - To be confirmed
15:15 Company presentation - CML Microsystems
15:30 Company presentation - KBC Advanced Technologies
15:45 Coffee
16:15 Company presentation - StatPro
16:30 Company presentation - To be confirmed
16:45 Company presentation - To be confirmed
17:00 Company presentation - Escher
17:15 Company presentation - To be confirmed
17:30 Close
This agenda is subject to change and alterations. More companies to be announced soon.
REGISTER NOW
The exhibition will be open from 10:45 to 17:30.
Coffee / lunch will be served within the exhibition.
This agenda is subject to change and alterations. More companies to be announced soon.
EXHIBITION
The exhibition will be open from 10:45 to 17:30.
Coffee / lunch will be served within the exhibition.
Dress code: business attire
VENUE
Business Design Centre
52 Upper Street
Islington
London N1 0QH
http://www.businessdesigncentre.co.uk/
Access map: http://www.businessdesigncentre.co.uk/VisitingUs
Closest tube station: Angel (3 min. walk) - Northern Line
SPONSOR
Cenkos Securities is an independent specialist securities firm focused on UK small and mid-cap companies.
We aim to be entrepreneurial, whilst seeking to establish long-term relationships with corporate and institutional clients.
Our directors and partners have on average more than 25 years' experience in the UK securities market. They have pioneered and led some of the most successful and innovative transactions in the UK securities market over the last decades.
REGISTER NOW
dreamcatcher
- 28 Dec 2013 17:56
- 109 of 183
Tipped in the Daily Mail today. Even better if it is a midas tip tonight. :-))
dreamcatcher
- 30 Dec 2013 19:15
- 110 of 183
:-))
dreamcatcher
- 14 Jan 2014 16:40
- 112 of 183
lol.
Trading Update and Notice of Results
RNS
RNS Number : 5527X
Regenersis PLC
14 January 2014
14 January 2014
REGENERSIS PLC
TRADING UPDATE AND NOTICE OF RESULTS
Regenersis Plc ("Regenersis" the "Company" or the "Group"), a strategic outsourcing partner to many of the world's leading consumer technology companies, issues this trading update in advance of its results for the six months to 31 December 2013, which will be announced on 17 March 2014.
Trading
The Board is pleased to confirm that performance for the half-year is expected to be in line with market expectations in a period that has again delivered double-digit sales and profit growth. Both the Emerging Markets and Advanced Solutions divisions are expected to deliver good earnings growth with the progress in the Advanced Solutions division being notable and most encouraging. Additionally, the Group's most recent acquisition, Digicomp, was successfully integrated and made a positive contribution.
Net debt at the half year will be slightly higher than market expectations, due primarily to working capital investments made in the Advanced Solutions division.
Operating Highlights
Having adopted a policy of focusing the Group on larger, higher value contracts, there has been a pleasing increase in both the number and the quality of significant new business wins during the period, which will begin to contribute in the second half of the year. These included a promising mix of cross-selling existing clients into new geographies, advanced solutions and technically-differentiated business; as well as new blue-chip clients won through competitive bids.
Cross-selling opportunities won in the period include:
· Entry of the B2B business into the USA with an existing European client, which will lead to the opening of the Group's first US depot facility in Memphis in spring 2014;
· A large existing mobile OEM client deciding to use our depot services in South Africa;
· A motherboard repair contract for a global mobile OEM client to be carried out in Poland, representing an emerging, technically-demanding trend for component-level repair as opposed to component exchange;
· A global refurbishment contract for a major mobile OEM with our partner Eco Asia.
Through large competitive processes we have also won:
· A new contract to deploy the IFT set top box diagnostic technology for a cable TV operator in Western Europe, our first IFT contract outside the UK and North America;
· A multi-year, multi-service contract for a global mobile operator covering Iberia, which is the first business for the Group with this client and has led to Regenersis being asked to open its first Portuguese depot facility;
· A deal to support the same network operator in their sizeable German insurance programme;
· A further new contract with a German insurer, supported through Poland.
Additionally the client balance shifted further towards multinational operators, as opposed to OEMs, which provides greater opportunities to sell Advanced Solution services as well as exposure to a better portfolio of manufacturers' business.
Digicomp secured its first new contract since acquisition, for tablet OEM services, demonstrating the competitive advantage enjoyed by Digicomp now it sits under the Group's umbrella.
Corporate Developments
· Further network internationalisation occurred during the period; the Group has commenced operations in Portugal, and will add a facility in Memphis, USA during the second half of the year.
· The remaining shares in Regenersis Russia were acquired for £0.56 million on 13 December 2013. This will now become a wholly-owned subsidiary and benefit from all of the Group's sales resource and efforts to grow further into this potentially significant emerging market.
· The Group continues to progress a number of exciting M&A opportunities in line with its stated strategy.
· As announced in December, the Group's total banking facilities with HSBC were increased from £23 million to £39 million and the term of the facility was extended to October 2016.
Matthew Peacock, Executive Chairman, said, "Our ambition and belief is that we can become the global leader in our business. I expect this next stage of growth to be as exciting and rewarding as the last, as we complete the roll-out of our depot network and the transition of the business to one which has a greater proportion of its earnings from the Advanced Solutions division."
"We believe these developments and the half year results underpin the market's expectation for a strong H2, as well as adding further confidence to the Board's expectations for continued good growth next financial year."
dreamcatcher
- 14 Jan 2014 17:16
- 113 of 183
Shares - Panmure Gordon adjusts its target price from 402p to 394p following the update. Cenkos Securities retains its view ‘that the shares can track towards 400p this year backed by a number of contract opportunities in the short-term and a longer-term management ambition to develop an innovative mobile device refurbishment business with higher IP and margins
dreamcatcher
- 15 Jan 2014 16:50
- 114 of 183
:-))
halifax
- 15 Jan 2014 16:58
- 115 of 183
RNS Hanover Investment Partners reduce from 21% to 10% is this a case of "grab the money and run"?
mitzy
- 15 Jan 2014 18:04
- 116 of 183
Superb..
worth 500p or more in 12 months time.
imo.
kayha
- 05 Feb 2014 10:20
- 117 of 183
WATCH: Jog Dhody, CFO of Regenersis, gives an overview of the company at the Innovators & Investors Forum
Click here to watch
dreamcatcher
- 06 Mar 2014 07:26
- 118 of 183
New Business Wins
RNS
RNS Number : 6228B
Regenersis PLC
06 March 2014
6 March 2014
REGENERSIS PLC
("Regenersis" the "Company" or the "Group")
NEW BUSINESS WINS
Regenersis, a strategic outsourcing partner to many of the world's leading consumer technology companies, is pleased to announce that, following the successful contract wins in the first half of the financial year, new business in the second half has continued to develop strongly.
Over the last few weeks, Regenersis has secured a number of new business wins in its Renew division which will commence in H2 of the current financial year, one of which is likely to be of particular significance in FY 2015.
The Group has won new business with a major global mobile network operator in Germany, where it will manage innovative device trade-in programmes, in a marketing rather than a supply chain led programme, representing a significant sector breakthrough. This contract will commence shortly and, after an implementation period, related costs and working capital investment, is expected to contribute to significant revenue and profit growth in FY 2015.
The Group has also won several other contracts which will make use of Regenersis' newly developed closed loop refurbishment and insurance fulfilment services. They will be fulfilled by the Group's refurbishment facilities across the world including Romania, Scotland and Sweden. Customers include:
· Several new insurance clients in northern Europe,
· A major operator in South Africa which will become a new customer of the Group, and
· An existing depot repair customer, a major operator in Europe, which is now making use of this new service offering.
The above new business wins are expected to have an annualised revenue of at least £10 million once they reach their full run rate.
Matthew Peacock, Executive Chairman of Regenersis, said:
"It is very pleasing to see the rapid progress we've achieved combining technologically advanced solutions with innovative marketing programmes. This powerful combination is becoming a source of considerable competitive advantage for Regenersis, as well as a significant opportunity for sustained growth."
"It is also the first time we have secured major contracts which move us from our clients' aftermarket and supply chain purse into a marketing and customer acquisition budget. We believe that this considerably broadens our scope for growth and development in the future."
"In the Board's view, these latest developments provide an even more encouraging outlook for further good growth in financial year 2015."
dreamcatcher
- 06 Mar 2014 13:11
- 121 of 183
Regenersis: Panmure Gordon Panmure Gordon raises target price from 394p to 423p and maintains its buy recommendation
dreamcatcher
- 12 Mar 2014 07:31
- 123 of 183
Contract win with Wincor Nixdorf in North America
RNS
RNS Number : 0021C
Regenersis PLC
12 March 2014
12 March 2014
REGENERSIS PLC
("Regenersis" the "Company" or the "Group")
REGENERSIS WINS 3-YEAR CONTRACT WITH WINCOR NIXDORF IN NORTH AMERICA
Regenersis is pleased to announce the award of a 3-year contract by Wincor Nixdorf to manage the repair of their Point-of-Sales terminals in North America. This new agreement includes the repair and overhaul of a wide range of products for the growing installed base of Wincor Nixdorf products. Regenersis has supported Wincor Nixdorf in Europe for many years.
Regenersis will open a new facility in Memphis, Tennessee, which will provide a base of operations for pursuing further opportunities with Wincor Nixdorf and other potential clients in the large and fragmented North American B2B/infrastructure aftersales service market, representing a significant new growth opportunity for the Group.
dreamcatcher
- 13 Mar 2014 20:57
- 124 of 183
Shares - Interim results 17 March, they expect the dividend growth to exceed market forecasts.
ExecLine
- 17 Mar 2014 09:31
- 125 of 183
From an Equity Development e-mail circular:
Dear ExecLine,
Regenersis is EMEA's leader for the repair and refurbishment of electronic devices, split into 3 divisions: Emerging Markets, Western Europe and Advanced Solutions.
Interim results show H1, 2014, in line with forecasts. Sales rose +11% to £99.7m (+17% constant currency) with Headline Operating Profit steady at £4.6m. Looking ahead, our FY 2014 PBT has been nudged down 3% to £9.8m reflecting a higher interest charge - albeit equally offset by a lower tax rate, leaving EPS unchanged at 17.9p. The dividend moves up to 4.0p (from 2.8p), thanks to an impressive 97% hike in the interim payout to 1.32p.
We anticipate another major profit surge, especially after winning a string of blue ribbon contracts in H1 2014. This can generate "mid-teens" organic growth in H2, and a 56% jump in adjusted EPS by FY 2016. Margins should expand on operational leverage and investment in Advanced Solutions.
The stock currently trades on a sector PER of 20x, declining to 12.8x by FY16. Our share price target remains at 430p
dreamcatcher
- 31 Mar 2014 18:12
- 126 of 183
dreamcatcher
- 31 Mar 2014 18:12
- 127 of 183
Regenersis PLC (RGS:LSE) set a new 52-week high during today's trading session when it reached 400.50. Over this period, the share price is up 85.88%.
dreamcatcher
- 31 Mar 2014 18:19
- 128 of 183
Regenersis: Panmure Gordon places both its target price and its buy recommendation under review.
dreamcatcher
- 05 Apr 2014 22:27
- 129 of 183
MIDAS SHARE TIPS UPDATE: Set-top box repair tip soars 384 per cent
By Joanne Hart, Financial Mail On Sunday
PUBLISHED: 22:05, 5 April 2014 | UPDATED: 22:05, 5 April 2014
Electronics repair firm Regenersis has been a huge success since specialist Matthew Peacock moved in as chairman three years ago. Tipped by Midas in October 2011 at 771⁄4p, the shares have increased almost fivefold to 3733⁄4p since.
Even though the performance has been impressive, there is still momentum in these shares. Last Monday, Peacock announced the £60 million acquisition of Finland’s Blancco, which specialises in erasing data from computers and mobiles.
Blancco is the world’s leading player in this field and customers include the CIA.
On the up: Even though the performance has been impressive, there is still momentum in these shares
On the up: Even though the performance has been impressive, there is still momentum in these shares
This is a huge area, particularly as a new EU law will soon fine firms up to 5 per cent of their turnover if they fail to look after customer data properly. Business is bound to boom once the new laws come into play.
Blancco should also fit neatly into the Regenersis stable. The group repairs phones, computers and set-top boxes.
Analysts predict a 13 per cent rise in profits to almost £10 million for the year to June 30, soaring to £18 million in 2015. The dividend is forecast to grow from 2.5p last year to 4p this and 5p next.
Midas verdict: Regenersis has been growing fast, but Peacock is extremely ambitious for the company. Stick with him.
dreamcatcher
- 23 Apr 2014 16:46
- 131 of 183
dreamcatcher
- 29 Apr 2014 16:38
- 132 of 183
NEW BUSINESS WINS
RNS
RNS Number : 7656F
Regenersis PLC
29 April 2014
29 April 2014
REGENERSIS PLC
("Regenersis" the "Company" or the "Group")
NEW BUSINESS WINS
Regenersis, a strategic outsourcing partner to many of the world's leading consumer technology companies, is pleased to announce a number of new contract wins.
The Group has won several new contracts in the depot repair business, which will be fulfilled through the Group's facilities in Spain and Germany. Customers include:
· Mobile phone repairs for Yoigo, which is the 4th largest mobile operator in Spain with over 4 million subscribers and is part of the Telia Sonera Group. Regenersis will become the repair partner for all the Sony mobile phones in the Yoigo estate and will cover both in warranty and out of warranty repairs.
· In what we believe is an industry first in Europe, Regenersis Germany has been awarded a contract by one of the world's leading, and most innovative, manufacturers of smartphones and other technology. The contract covers both in-warranty (non-carrier) and out-of-warranty (carrier/non carrier) devices, and is the first of its kind in Germany. Regenersis has been working with this manufacturer as an Approved Service Partner for many years and represents a logical and very significant strategic step for Regenersis in Europe.
In the Renew division, the Group is pleased to announce the launch a new mobile insurance proposition with a key mobile operator in Poland under the Digital Care brand.
· This includes an LCD Protection Plan and is a first to market offering making Digital Care the number 1 mobile protection provider in Poland. The scheme is underwritten by a large Polish underwriter.
· The product offering includes a 24 month cover for accidental damage to the customers' smart phone screen, which is an increasingly growing problem.
The above new business has been won since the half year results. They will underpin the sales growth already anticipated for next year.
Matthew Peacock, Executive Chairman of Regenersis, said:
"It is extremely pleasing to see these new pieces of business which represent significant strategic steps for Regenersis in moving us towards establishing ourselves us as the leading aftermarket services provider in the world."
dreamcatcher
- 08 May 2014 13:54
- 133 of 183
Ex dividend Wed 14 May 1.32p
dreamcatcher
- 15 Jul 2014 07:07
- 134 of 183
Trading Update and Notice of Results
RNS
RNS Number : 2929M
Regenersis PLC
15 July 2014
15 July 2014
REGENERSIS PLC
TRADING UPDATE AND NOTICE OF RESULTS
Regenersis plc ("Regenersis" or the "Group"), a strategic outsourcing partner to many of the world's largest technology brands, issues this trading update in advance of its results for the year ended 30 June 2014, which will be announced on 23 September 2014.
Trading
The Board is pleased to confirm that performance for the year will be in line with market expectations, in a period in which the Group has again delivered double-digit sales and profit growth and an improving operating margin. The Advanced Solutions Division has shown particularly good profit growth in the period. The Group's net cash position at the financial year end will also be in line with market expectations.
Blancco
Since its acquisition on 17 April 2014, Blancco has performed ahead of management's initial expectations and the business is expected to show continued significant growth in the next financial year to 30 June 2015.
In April 2014, Blancco agreed a partnership with Kroll Ontrack, previously its largest competitor, whereby Kroll Ontrack promotes Blancco's data erasure software solutions. This partnership has started well and is already delivering new business.
The changes to Article 17 of the European Union's Data Protection Regulation announced in March 2014 stipulate "the right to be forgotten" and have profound implications for data controllers. Blancco's offering addresses this need and discussions with Regenersis' customers to adopt Blancco's core product have begun globally.
Xcaliber Technologies
Xcaliber Technologies' mobile diagnostics and issue resolution software complements Blancco's corporate data erasure services as well as Regenersis' Repair, Recommerce and Digital Care services. The Group is working with existing customers to bring to market a bundled offering combining these mutually complementary solutions.
In the last six months, Xcaliber Technologies has contracted its first significant mobile diagnostics revenues and launched three important live pilots of its solutions with a major US mobile operator, a major European mobile operator and a major US repair company.
As a result of this encouraging pipeline, Regenersis has agreed to provide a further US$3.5m of funding, taking its equity stake in Xcaliber Technologies to 49%. This development capital will be used to secure the growth of the business and the large potential contracts that already exist, as well as to progress a bundled diagnostic platform with Blancco and other growing Regenersis technologies.
M&A
In addition to Xcaliber Technologies, the M&A pipeline contains several exciting prospects and we look forward to providing a progress report in our full-year results. The Group is focusing particularly on deals which will expand its technology suite and also those that will extend its global footprint. The Board remains confident in the Group's ability to source accretive investments and to integrate them successfully.
Matthew Peacock, Executive Chairman of Regenersis, said:
"In 2014, we have focused on building the Group's software and system-driven businesses both via corporate activity and through organic developments started in 2012 and 2013. The Group is now active in 22 countries. Advanced Solutions' contribution to Group operating profit is expected to grow to around 60% in 2015, from 31% in 2013, and to increase further in the coming years.
"It is these developments in Advanced Solutions which underpin the Board's expectation of further double digit growth in the next financial year and beyond."
dreamcatcher
- 18 Sep 2014 20:38
- 135 of 183
Final results Tues 23 Sept
dreamcatcher
- 27 Sep 2014 20:20
- 136 of 183
Final Results
RNS
RNS Number : 3159S
Regenersis PLC
23 September 2014
23 September 2014
REGENERSIS PLC
(AIM: "RGS")
PRELIMINARY RESULTS FOR THE YEAR ENDED 30 JUNE 2014
Regenersis Plc ("Regenersis" or the "Group") is pleased to announce its final results for the year ended 30 June 2014, which show a strong financial performance and good growth, along with a number of positive corporate developments, including acquisitions after the year end.
Group Financial Highlights
· Revenue increased by 10% to £197.5 million (2013: £179.7 million) - up 18% in constant currency.
· Headline Operating Profit* ("HOP") increased by 16% to £11.0 million (2013: £9.5 million) - up 22% in constant currency.
· Operating Profit decreased to £0.5 million (2013: £7.1 million) primarily as a result of exceptional acquisition and restructuring costs.
· The recommended final dividend per ordinary share is 2.68p (2013: 1.83p), giving a total dividend for the year of 4.0p (2013: 2.5p) - up 60%.
· The Group's investment in capital expenditure and research and development increased to £6.7 million (2013: £4.3 million).
· Headline operating cash flow** of £4.5 million (2013: £12.9 million) with headline cash conversion of 41% (2013: 135%), being lower than previous periods primarily due to working capital investments made in the rapidly growing Advanced Solutions division.
· Equity fundraising of £100 million in April 2014, including the acquisition of Blancco Oy Limited ("Blancco").
· Net cash at the year end was £20.6 million (FY 2013: £1.9 million net debt), following the equity fund raising in April 2014.
· Adjusted EPS*** decreased by 4% to 16.16p (2013: 16.80p) and basic EPS decreased by 48% to (5.45p (2013: 10.53p). The decrease in the Adjusted EPS is a result of the Placing undertaken in April 2014, without which the adjusted EPS would have been 18.19p, an increase of 8%.
*'Headline Operating Profit' is the key profit measure used by the Board to assess the underlying financial performance of the operating divisions and the Group as a whole. 'Headline Operating Profit' is stated before amortisation or impairment of acquired intangible assets, exceptional acquisition and restructuring costs and share-based payments.
**'Headline operating cash flow' is a key internal measure used by the Board to evaluate the cash flow of the Group. It is defined as operating cash flow excluding taxation, interest payments and receipts, exceptional acquisition and restructuring costs.
***'Adjusted EPS' is an adjusted measure of earnings per share based on adjusted earnings. Adjusted earnings are stated before amortisation or impairment of acquired intangible assets, exceptional acquisition and restructuring costs, share-based payments, unwinding of the discounted contingent consideration and adjustments to estimates of contingent consideration
Divisional Highlights
· Advanced Solutions divisional HOP of £7.5 million (2013: £3.6 million) - up 108%.
· Emerging Markets divisional HOP of £6.7 million (2013: £5.9 million) - up 14%.
· 91% of divisional HOP generated by the strategically important Advanced Solutions and Emerging Markets segments.
· Total HOP before central corporate costs increased to £15.6 million (2013: £11.7 million) - up 33%, while central corporate costs of £4.6 million (2013: £2.2 million) increased, as the Group invested in senior management and other aspects of its future growth platform.
Operating Highlights
· The senior management team was significantly strengthened, most notably with new roles: Chief Operating Officer; Managing Director, Renew; Chief Information Officer; and Director of Sales, Innovation and Marketing.
· Regional operations were brought fully into an integrated global operations structure for the first time under the new COO and the Group's Kaizen continuous improvement programme was extended from the UK to Poland and Spain.
· New technical capabilities were introduced, including notably: an advanced LCD screen delamination/relamination and refurbishment facility in Romania, Europe's first facility of this type; introduction of B2B operations to the United States (Memphis); installation of Xcaliber smartphone diagnostic systems in the Group's largest mobile phone repair facilities; and roll-out of in-house developed Oktra set top box diagnostics systems into our set top box repair facilities.
· Digital Care won the principal smartphone insurance contract at each of the top three mobile operators in Poland with its innovative service offer. This outstanding result positions Digital Care as the clear market leader in mobile insurance in Poland and provides an excellent platform for international expansion.
· In April 2014, Blancco agreed a partnership with Kroll Ontrack, previously its largest competitor, whereby Kroll Ontrack promotes Blancco's data erasure software solutions. This partnership has started well and is already delivering new business.
· Elsewhere there was a significant increase in the quantity and quality of new business won in the second half, including a large contract with an industrial Group in Europe to provide repair and reverse logistics for a range of payment devices and a series of insurance-related fulfilment and repair contract for clients in Mexico, Poland, Romania, and other territories.
Corporate actions and M&A update
· As part of the £100 million fundraising, Regenersis acquired Blancco, a global market leader in the provision of data erasure software, for €60 million in April 2014.
· Blancco has performed ahead of management's initial expectations and the business is expected to show continued significant growth in the next financial year to 30 June 2015. Blancco is planned to become the focal point of a portfolio of software products and services which the Group is in the process of expanding by acquisition.
· In July 2014, Regenersis increased its equity stake in Xcaliber Technologies ("Xcaliber") to 49% by injecting US$3.25 million of cash funding into the business. Xcaliber and Blancco have several significant areas of synergy including the opportunity to launch bundled smartphone diagnostics and erasure propositions, and to share sales and operational resources.
· In September 2014, Regenersis acquired 100% of the share capital of SafeIT Security Sweden AB ("SafeIT") for SEK 16.0 million (£1.4 million). SafeIT is a leading specialist cloud data erasure business in the emerging field of virtual and server data erasure management. Its services and solutions help clients to identify and permanently erase data in complex cloud environments. This acquisition extends Blancco's market leading position in data erasure into the rapidly growing cloud storage market.
The M&A pipeline remains strong, with opportunities to further extend the Advanced Solutions portfolio around the Blancco brand. Globally the sector remains immature and therefore ripe for consolidation.
Regenersis also announces the retirement of Michael Peacock, Non-executive Director and Senior Independent Director from the Board with effect from 26 November 2014. Michael joined the Board in 2011 and has played an important role in the growth of the Company. A search for a replacement Senior Independent Director has now been commenced and Regenersis would like to make an appointment as quickly as possible, recognising the importance of this position for maintaining best practice corporate governance.
Strategy Update
Regenersis strategy focuses around two client deliverables:
· Delivering consistent high quality Depot repair services across the world; and
· Developing innovative Advanced Solutions services, which improve our clients' businesses and enhance Regenersis's position as a partner.
The acquisition of Blancco has transformed the Advanced Solutions portfolio, making it the majority of the Group in terms of share of likely future profitability and value potential. The business specialises in data erasure solutions and represents a growth in the service range that the Advanced Solutions division offers customers. Additionally Blancco has opened up a new set of M&A opportunities, leveraging its market-leading brand, customer relationships, and large direct sales force. The recent Xcaliber and SafeIT transactions are the first steps in this direction.
Blancco has outstanding opportunities because it has unique technical capabilities which address new, high growth areas in data erasure:
•
Corporate data erasure management is the key focus, where the traditional challenge of wiping sensitive corporate data from PCs at the end of their life is evolving into a multi-headed challenge of complying with stringent data protection legislation in an environment of pervasive mobile devices and cloud data storage; and
•
Cloud or virtual data erasure, where the acquisition of SafeIT brings in-house the leading technical capabilities available. This is another area of potentially very significant opportunity for the Group.
•
The focus of initiatives in Blancco is on effective deployment to advance this agenda.
Xcaliber Technologies brings complementary capabilities to Blancco and Regenersis is integrating these businesses at various levels to realise this opportunity fully. There exists product/proposition and operating/salesforce synergies with the potential to enhance the growth and competitiveness of both businesses.
Elsewhere in the organic development of the business, new business wins during the year just ended again populated new "pixels" in the matrix of countries and services of the Group (from 45 to 79). It also further shifted the business mix towards the operator segment (including mobile, pay TV, insurance companies and other corporates) as compared to OEMs) from 21% to 28%. The Blancco acquisition has additionally extended the number of territories in which Regenersis has a physical presence to 22. In the remainder of the Group, the focus has been on building the quality of the business within the operating footprint.
The most notable success in terms of organic business development in the year was achieved by Digital Care in Poland, as noted above in the operating highlights. This success clearly validates Digital Care's unique proposition, which is the result of two years of development. The Group is looking to extend this success across other geographies.
In conclusion the Group continued to evolve its mix of current and future opportunities towards Advanced Solutions during the year, notably with Blancco, Xcaliber, and Digital Care. The strategy remains fundamentally unchanged: pursuing depth and breadth in a portfolio of Emerging Markets and Advanced Solutions business; and achieving this goal through a focus on people, global integration, and M&A.
Outlook
· Current trading in local currency terms is in line with our expectations and the Group continues to target double digit growth in revenue and profitability.
· Strong sterling pressures felt in the last financial year have continued in the year to date.
· New business wins have progressed very well and are significantly ahead of the run rate at this stage for last year.
· Advanced Solutions as a proportion of Group revenue is expected to continue to increase rapidly.
· Opportunities for global growth, both organically and by acquisition, remain strong.
Matthew Peacock, Executive Chairman of Regenersis, said:
"Overall the year just ended was transformative in terms of the shape of the Group and its prospects for the future. The Group has become an exciting Advanced Solutions-led business growing via organic progress and M&A. The formula for this development over the last few years has been our focus on the three "game changers" - people, global integration, and M&A - and we will continue to follow this approach next year and beyond. I am looking forward to further expanding a number of strong performing divisions (organically and via bolt-on M&A) which are demonstrating a proven track record of growth."
js8106455
- 01 Oct 2014 10:23
- 137 of 183
Watch: Matthew Peacock, Executive Chairman & Jog Dhody, CEO Regenersis - Final Results Video
Click here
js8106455
- 01 Oct 2014 10:29
- 138 of 183
Watch: Regenersis - Highlights of the final results
Click here
dreamcatcher
- 27 Oct 2014 16:15
- 139 of 183
New Business Wins
RNS
RNS Number : 3082V
Regenersis PLC
27 October 2014
27 October 2014
REGENERSIS PLC
("Regenersis" the "Company" or the "Group")
NEW BUSINESS WINS
Regenersis plc, a strategic outsourcing partner to many of the world's largest technology brands, is pleased to announce significant new contract wins in its Depot business:
· In Mexico, the Group has been awarded a repair and refurbishment contract with Sony Mobile, a division of Sony Corporation. This contract has already begun operational ramp up in our Mexico City facility.
· Regenersis Poland has secured an addition to the Group's strategic partnership with HTC, under which additional device volumes from EMEA will be processed by Regenersis Poland. This contract will materially increase the volume of HTC units handled by Regenersis from the second half of the current financial year.
· An aftermarket and repair service solution contract for a leading US based, global company in the Business to Business segment, has been awarded to the Group, which will be delivered through three of our European facilities and includes component level repair and returns management.
Further, Regenersis has secured several new repair contracts for leading insurance customers to be serviced from our Poland and Romanian facilities, including screen refurbishment and advanced motherboard repairs.
The Group expects these new business wins to deliver in excess of £15 million annualised revenue for the Depot division once they have reached their anticipated run rate.
Matthew Peacock, Executive Chairman of Regenersis, said:
"We are delighted that Sony has chosen to partner with Regenersis in Mexico and look forward to working with them. The extension of our established contract with HTC speaks to the success of our working relationship, which has progressively grown since we started working together.
"These new contracts underpin management's existing growth forecasts for the Depot division of the Group this year."
dreamcatcher
- 07 Nov 2014 07:16
- 140 of 183
Proposed Capital Reduction & Notice of GM
RNS
RNS Number : 4133W
Regenersis PLC
07 November 2014
7 November 2014
REGENERSIS PLC
("Regenersis" or the "Company")
PROPOSED CAPITAL REDUCTION AND NOTICE OF GENERAL MEETING
Regenersis plc, a strategic outsourcing partner to many of the world's largest technology brands, announces that it will today be posting a circular to shareholders, which sets out a recommended proposal by the Board to increase the distributable reserves of the Company (the "Circular").
The proposals, which comprise a capital reduction, are conditional upon, amongst other things, the Company obtaining appropriate shareholder approval at a General Meeting.
Background
Since 2011, the Company has undergone a rapid period of expansion. In order to execute its growth strategy, distributable reserves have been utilised, amongst other things, to fund the costs associated with merger and acquisition activity undertaken by the Group. Over the same period, the amount held in the share premium account has increased significantly as a result of the Company issuing shares at a premium to their nominal value.
As a result, the Company's accounts for the year ended 30 June 2014 show it to have an accumulated profit on its distributable profit and loss account of £3,490,000 and a balance on its share premium account of £121,737,000.
A share premium account is an undistributable reserve and, accordingly, the purposes for which the Company can use it are extremely restricted. In particular, it cannot be used for paying dividends or undertaking share buybacks.
The Board is therefore recommending that a proportion of the amount held in the share premium account be reduced and transferred to the Company's profit and loss account to create further positive distributable reserves, in order to give the Board the flexibility to distribute profits to shareholders as dividends, or possibly by way of share buybacks, if it is considered appropriate at the time.
The Circular contains a Notice of General Meeting which will be held on 26 November 2014, the same day as the Company's Annual General Meeting.
The Circular and Notice of General Meeting will be available on the Company's website later today.
dreamcatcher
- 07 Nov 2014 12:46
- 142 of 183
I read it that there is £3,490,000 in the distributable profit and loss account and added to it a proportion of the £121,737,000 amount held in the share premium account, in due time to create further positive distributable reserves. In the form of paying dividends or undertaking share buybacks.
dreamcatcher
- 07 Nov 2014 13:23
- 144 of 183
Perhaps if the company was clear on :- Are they were going to buy back shares or give a dividend or indeed both . Also how much are they going to transfer? RNS could of had a lot more facts in the detail.
dreamcatcher
- 07 Nov 2014 14:42
- 146 of 183
Naked Trader 29/10/14 update - I bought Regenersis (LON:RGS) after it announced £15 million in new contracts, it's been looking well oversold recently.
The contract for RGS strengthens its position and it looks an interesting play to hit 250 and then 300 again
ExecLine
- 20 Nov 2014 13:27
- 147 of 183
Here's a link to Blancco:
http://www.blancco.com/uk/frontpage/
Blancco is now owned by Regenersis and is the world leader in providing Certified Erasure facilities for both the corporate and private sectors.
All organizations that are doing business in or with organizations in the European Union should be aware of upcoming EU Data Protection regulations.
The European Union Draft Regulation and Draft Directive could become effective at the end of 2014 giving member states two years from the date of enactment to bring the Draft Regulation into effect and transpose the Draft Directive into their national laws.
Cerifiable Data Erasure is going to be absolutely massive!
Sanctions for violation of these new EU requirements are predicted to range from
250,000 Euros to 100 million Euros or 0.5% to 5% of turnover for the most serious offenses.
Part of the EU Data Protection Reform Package (both Draft Regulation and Draft Directive) will include the "right to be forgotten", the "right to erasure" and the "right to data portability", so all organizations should be prepared to fulfill these requirements.
Organizations are obliged by law to ensure the safe disposal of sensitive information or face the penalties of non-compliance. Failure to erase data could result in:
Identity theft
Time in prison
Federal and/or civil liability
Exorbitant fines or lawsuits
Irreparable damage to an organization’s reputation
Loss in consumer confidence
Decline in revenue due to a tarnished reputation and loss of clients.
Have a read at some of the very stiff International Penalties in the tables at the bottom of the following page:
http://www.blancco.com/en/benefits/regulatory-compliance/
ExecLine
- 27 Nov 2014 08:17
- 148 of 183
Blancco Launches Canadian Partner Program for IT Asset Disposal Vendors
BY PR NEWSWIRE
NOVEMBER 26, 2014 10:00 AM EST
ABBOTSFORD, British Columbia, November 26, 2014 /PRNewswire/ --
Erasure solutions from Blancco Partners help ensure compliance with the Personal Information Protection and Electronic Documents Act (PIPEDA) and other regulations
Blancco, the global leader in data erasure and computer reuse solutions, has launched a Partner Program to support Canadian providers of professional IT asset disposal (ITAD) services. Joining as the first member of the ITAD Partner Program is GEEP, a global provider of safe, secure reuse and recycling of waste electric and electronic equipment (WEEE) services.
Blancco's ITAD Partner Program was created for ITAD, electronics recycling and leasing organizations that are industry leaders, such as GEEP. The program is designed to streamline erasure processes required for safe reuse, disposal and destruction of IT equipment. It also addresses increasingly complex regulations for ITAD specialists and their enterprise customers with solutions that provide auditable erasure reports.
"Our partners and their customers recognise the growing compliance and legislative requirements around data protection, both globally and in Canada," said Christopher Eeg, Managing Director, Blancco Canada. "The Partner Program supports the commitment our partners have to professionally protect customer data with world-class solutions that ensure legislative compliance."
The Privacy Commissioner of Canada has called for increased corporate responsibility around IT security and data loss prevention. Working with Blancco Partners, enterprises can feel confident of addressing these calls, as well as amendments to PIPEDA and the forthcoming European Union General Data Protection Regulation.
CIO, CTO & Developer Resources
"Providing customers with the best security solution available is essential to our business," said Wallace MacKay, Vice President of Corporate Development, GEEP. "Partnering with Blancco, we can verify complete data erasure of all IT assets we manage and provide erasure reports necessary for regulatory compliance. The Blancco standard is a brand trusted by us and our clients."
About Blancco
Blancco is the proven data erasure solution for millions of users around the globe. As the global leader in data erasure and computer reuse solutions, Blancco offers the most certified data erasure solutions within the industry. The company serves users across a wide range of industries, including banking, finance, government and defense. The company's products are highly valued by IT asset disposal professionals around the world. Blancco operates from an extensive network of international offices and partners across Europe, North America, the Middle East, Russia, Asia and Australasia. Blancco is a wholly owned subsidiary of Regenersis, a strategic outsourcing partner to many of the world's leading consumer technology companies. More information is available at http://www.blancco.com.
About GEEP
GEEP is committed to effectively and responsibly managing the consequences of the electronic age. We provide a means for safe, secure reuse and recycling of waste electric and electronic equipment (WEEE) while providing investment recovery for businesses to maximize the management of their IT assets. The company employs state-of-the-art recycling facilities using innovative equipment for electronics processing and the management of IT and Telecom assets. Certified to the highest standards in the industry, GEEP has consistently won accolades for its processes, sustainable operations and best-in-class management. With a broad geographical coverage at ten locations in the U.S., Canada and Costa Rica; and over 500 employees, GEEP is currently processing 130 million pounds of e-waste and data securing and remarketing over 500,000 electronic products for reuse each year. GEEP is privately held by the Giampaolo Group of Companies, North America's principal fully integrated metal management company, however operates as a standalone business.
For more partnership information, visit this link.
Media Contact
Monica Shaw
+1-770-367-9534
mshaw@carabinerpr.com
Blancco Canada
Christopher Eeg, Managing Director
+1-604-853-3833
canadasales@blancco.com
Published November 26, 2014 – Reads 143
Copyright © 2014 SYS-CON Media, Inc. — All Rights Reserved.
Syndicated stories and blog feeds, all rights reserved by the author.
dreamcatcher
- 19 Dec 2014 15:53
- 149 of 183
New Business Wins
RNS
RNS Number : 2471A
Regenersis PLC
19 December 2014
19 December 2014
REGENERSIS PLC
("Regenersis" the "Company" or the "Group")
NEW BUSINESS WINS
Regenersis plc, a strategic outsourcing partner to many of the world's largest technology brands, is pleased to announce five new contract wins or contract extensions in its Depot business:
· A new contract with HTC covering repair in the USA and Mexico. This continues to widen the
Group's strategic partnership with HTC and in particular broadens the client base in our Memphis
facility. Both contracts will start in calendar year mid-2015.
· The extension of an existing refurbishment contract with a leading Global mobile OEM to include full screen refurbishment, serviced from our new refurbishment facility in Romania.
· A repair contract for Lenovo for their Russian tablet and notebook products which is to be serviced from our Moscow facility and further expands the number of leading manufacturers supported there.
· A contract servicing Asus branded notebooks, tablets and phones in Germany. The contract includes both in warranty and out of warranty repairs.
· A long term contract with Ingenico Healthcare Germany who are the market leader for e-health terminal solutions. The contract provides repair, device management and refurbishment activities serviced from our facility in Sömmerda, Germany.
The group expects these new business wins to deliver in excess of £17 million annualised revenue for the Depot division once they have reached their anticipated run rate.
Matthew Peacock, Executive Chairman of Regenersis, said:
"These new contracts support our market share gains in the Depot division and are within our forecasts for the Depot division this year and next".
dreamcatcher
- 02 Jan 2015 16:08
- 150 of 183
Our system’s recommendation today is to BUY. The BULLISH HOMING PIGEON pattern finally received a confirmation because the prices crossed above the confirmation level which was at 209.0000, and our valid average buying price stands now at 213.2500. The previous SELL signal was issued on 08/12/2014, 23 days ago, when the stock price was 218.7500. Since then RGS.L has fallen by -2.51%.
Market Outlook
Let’s jump on our white horses and go for a bullish ride. The bullish pattern that was previously identified is finally confirmed and a BUY signal is generated. The market is telling you about a new profit. Do not miss this bullish opportunity.
https://www.britishbulls.com/SignalPage.aspx?lang=en&Ticker=RGS.L
dreamcatcher
- 14 Jan 2015 15:45
- 151 of 183
Trading Update
RNS
RNS Number : 0756C
Regenersis PLC
14 January 2015
14 January 2015
REGENERSIS PLC
("Regenersis" the "Company" or the "Group")
TRADING UPDATE AND NOTICE OF RESULTS
Regenersis Plc, a strategic outsourcing partner to many of the world's leading consumer technology companies, issues this trading update in advance of its results for the six months to 31 December 2014, which will be announced on 17 March 2015.
In the first half of the financial year, performance of the Group was in line with expectations.
The Board is pleased by the progress of Depot Solutions which delivered good growth versus the prior period. The continuing businesses of Advanced Solutions have grown and the Board is also encouraged by the continued good performance of Blancco (the full benefits of this and profits from the Digital Care business will be seen in the second half).
dreamcatcher
- 14 Jan 2015 17:49
- 152 of 183
14 Jan Panmure Gordon 403.00 Buy
dreamcatcher
- 05 Feb 2015 19:39
- 154 of 183
The essential guide to aim stocks in Shares today -
Regenersis - Electronic data erasure and product recycler Regenersis has endured a tough 12 months. Its share price dropped 32% in 2014 after restructuring costs saw the business barely break even at the operating level.
dreamcatcher
- 05 Mar 2015 18:28
- 155 of 183
dreamcatcher
- 12 Mar 2015 16:49
- 156 of 183
12 Mar Panmure Gordon 403.00 Buy
dreamcatcher
- 22 Mar 2015 20:03
- 158 of 183
IC - Regenersis generates growth potential.
The depot solutions business gained £32m of new business during the first half, going some way to compensate for its now defunct UK mobile business. The shares are trading on 11 times this years earnings, which , considering the growth potential , looks like value.
js8106455
- 24 Mar 2015 10:05
- 160 of 183
Regenersis - Interim Results Presentation
click here
Bullshare
- 02 Apr 2015 16:38
- 161 of 183
Shares Investor Evenings showcase up to four presentations from leading companies bringing them together in one room for one evening only.
Directors present their latest plans regarding development and growthAn opportunity to talk directly to the companies and personally put forward your questionsThe chance to network with other attendees over drinks and canapés - private investors, wealth managers, private client brokers, fund managers and financial institutionsWho Should Attend?
The evening exposes investors to companies across various sectors. Perfect for existing investors as well as those looking for new investment opportunities.
Date:
Wednesday 29th April 2015
Venue:
Novotel Tower Bridge, London EC3N, 10 Pepys Street, London, EC3N 2NR
Event Timings:
18.00 | | Registration and coffee |
18.30 | | Presentations • John Cronin, Executive Chairman - Cyan Technology (CYAN) • Crispin Simon, CEO - REX Bionics (RXB) • Jog Dhody, CFO - Regenersis (RGS) • Dr. Satu Vainikka, CEO - Valirx (VAL) |
20.30 | | Drinks reception and canapés |
21.30 | | Close |
Attendance is free, but spaces are limited.
Register now to secure your place!
Cyan Technology (CYAN)
 | | Cyan is an integrated system design company headquartered in Cambridge, with customers, staff and partners across many of the world’s largest emerging markets. It provides a communication platform that enables the measurement and control of energy consumption for smart metering and lighting. Cyan is focussed on emerging markets, where it’s low cost, low power solution provides significant customer benefits. It delivers integrated solutions to utilities, municipalities and local authorities, with customer wins to date in India, Brazil and China |
Regenersis (RGS)
 | | Regenersis is a leading, strategic outsourcing partner to the world’s premier consumer technology brands. Regenersis has built an increasingly global network of repair centres, delivered double digit revenue and profit growth, through cross-sell related services to major OEMs and network operators. In addition, the Group has traction with its scalable, high margin Advanced Solutions offering across the mobile and set top box markets. |
REX Bionics (RXB)
 | | Rex Bionics Plc (The Rex Bionics Group) is the global technology leader in robotic walking devices (REX). Uniquely, REX® provides independent mobility to wheelchair users and other mobility impaired persons using advanced robotic technology, custom-designed electromechanical actuators, precision engineering, and specialised networking systems. Today there are two primary REX devices available; an adjustable REX Rehab for use in rehabilitation centres, and a streamlined, fit-for-purpose REX Personal made for each individual’s specific medical and physical requirements enabling the user to perform tasks and functions previously unavailable. Rex Bionics is a rapidly growing, exciting, innovative organisation which is proud to provide advanced robotics technology to people everywhere. |
Valirx (VAL)
 | | Valirx Plc is an oncology-focussed Biopharmaceutical Company, developing treatments and diagnostics. Technologies are selected by using rigorous clinical and commercial processes to address unmet market needs. Clinical lead product is VAL201, a peptide for prostate cancer with follow-on indications in ovarian and breast cancers and endometriosis. Product VAL401, is a small molecule reformulation for lung cancers. The Company’s proprietary technology platform, GeneICE, enables selective silencing of rebellious genes’ inappropriate activity. VAL101, the first GeneICE therapeutic, targets and reduces expression of Bcl-2, implicated in about half of cancers. GeneICE extension to neurology and inflammatory diseases will follow. A novel diagnostic, the Nav3 system, detects pre-cancerous, cancerous and metastatic cells in tissue samples even before a tumour forms; indicating potential malignant formation. |
Sponsored by:
cp1
- 13 Apr 2015 10:34
- 162 of 183
Somebody should ask the FD at the presentation why he runs a negatively geared balance sheet. This looks an attractive business but to me the FD is too inexperienced and clearly has annoyed a few in the city hence such a low rating. A share buyback / special dividend is what is required to restore some confidence. Until then it's a flat liner imo.
cp1
- 13 Apr 2015 12:56
- 164 of 183
It is plain dumb what they have done. I took a good profit when they raised the money for Blancco thinking I'd re-enter around 300p. That was over 12 months ago and at 210p I'm hardly chomping at the bit to start buying given the share price appears to be going no where. They raised too much cash which is now dragging eps down as it sits doing nothing. Either bolt on smaller rivals or return the cash. My only interest here is now via our share club and, whilst I think they have a great future, they certainly need to change things to get investors back excited.
Perhaps the arrival of Polygon and Reade Eugene Griffith on the share register this last couple of weeks will shake things up..
Otherwise wake me up once the FD has gone or changed his stance.
cp1
- 29 Apr 2015 08:41
- 165 of 183
Regenersis the share with great potential but imo a not very good FD running the show.
Just hope no one asks to pull up the 1 year chart at tonight's presentation. Any new investors should be warned of the permanent stock overhang as well.
I wish I could get to the presentation but business commitments.
cp1
- 07 May 2015 08:32
- 167 of 183
I don't think this will recover until the FD Dhody gets moved out. He's running this like a family business rather than looking after shareholders. Have you seen the remuneration packages and bonuses dished out last year? The institutions who stumped up 100 million euros at 345p must feel more than done over when they see how he's running things. As ever failure is rewarded once a company has PLC after its name.
The only hope here is if activist Polygon start building a stake and perhaps shake things up. AIM again!
cp1
- 08 May 2015 14:31
- 169 of 183
Taxi for Jog!! Will the city push him? The shareprice suggests so.
Share club meeting Saturday night. I doubt they'll be happy with me having suggested this to them near 350p. Ouch!! I'll keep my head down..
cp1
- 18 May 2015 16:00
- 171 of 183
Even the volume has dropped away here now. In all seriousness how is Dhody still running the finances here??
He's presented to investors (prospective) a few weeks ago (shares down 10% since) great work not.
Why hasn't he sanctioned a share buyback if the shares are such a good investment? It's a question that was asked at the interim presentation.
Why raise so much cash and not grow through acquisitions?
The shares are down a huge 40% from the placing over a year ago and nearly 50% from their peak.
and I thought Hanover were smart cookies!
Someone is accountable or is it a case of snouts in bonus trough???
dreamcatcher
- 18 May 2015 16:12
- 172 of 183
You sound just the person for his job. :-))
cp1
- 19 May 2015 10:06
- 173 of 183
I've also noted since they've bought this 'great' company Blancco they've never once mentioned it has won a contract or actually done anything. 1 year and nothing ever mentioned about it. The buying of Blancco coincided with the share price collapse, more than ironic. All a bit strange this one. I think I'll buy a few outside of nominee account pre AGM just for a question and answers laugh. Always fun to see directors stutter and squirm when one asks the questions linking bonuses to share price performance. This one should be a hoot.
dreamcatcher
- 14 Jul 2015 16:43
- 174 of 183
Trading Update
RNS
RNS Number : 9273S
Regenersis PLC
14 July 2015
14 July 2015
REGENERSIS PLC
("Regenersis", the "Company" or the "Group")
TRADING UPDATE AND NOTICE OF RESULTS
Regenersis, the global provider of electronic repair, diagnostics and data erasure software, issues this trading update in advance of its results for the year ended 30 June 2015, which will be announced on 22 September 2015.
Notwithstanding Sterling's continued strength through the reporting period, the Group's profitability in the financial year to 30 June 2015 will be in line with market consensus.
Depot Solutions achieved in reported Sterling and in constant currency, growth in revenue and headline operating profit in the year just ended. However, post the year end, Depot Solutions has been notified, following a competitive tender process in which the Group participated fully, that one of its larger clients intends to consolidate its European business with another supplier which is anticipated to adversely impact Depot performance in FY2016. This reflects an ongoing consolidation trend in the sector, of which Depot Solutions has been a beneficiary in recent years.
Blancco (currently reported within Advanced Solutions) achieved year on year sales growth of 27% in its first full year as part of the Group, driving headline operating profit growth in constant currency terms of approximately 45%. The Group will report Blancco separately from the rest of Advanced Solutions at final results and going forwards, reflecting its increasing importance to the Group.
Given the above, the Board believes the outlook for FY2016 is for modest growth in headline operating profit, with strong growth in the Advanced Solutions and Software activities offset by a reduced contribution from Depot activities. During 2016, the Board will focus on actions to maximize shareholder value.
Energeticbacker
- 17 Jul 2015 17:40
- 175 of 183
Regenersis PLC featured in our weekly round-up of announcements from AIM, see more at http://www.investorschampion.com/blog/
dreamcatcher
- 11 Sep 2015 17:03
- 176 of 183
A company to stay well clear of at the moment .
Naked Trader today - RGS (LON:RGS) kept going down so sold for a loss of £553 . Not sure what's up or not there.
dreamcatcher
- 19 Oct 2015 17:45
- 178 of 183
A strong recovery.
Bullshare
- 25 Nov 2015 14:14
- 179 of 183
Shares Investor Evenings showcase up to four presentations from leading companies bringing them together in one room for one evening only.
Directors present their latest plans regarding development and growthAn opportunity to talk directly to the companies and personally put forward your questionsThe chance to network with other attendees over drinks and canapés - private investors, wealth managers, private client brokers, fund managers and financial institutionsWho Should Attend?
The evening exposes investors to companies across various sectors. Perfect for existing investors as well as those looking for new investment opportunities.
Date:
Tuesday 15th December 2015
Venue:
Novotel Tower Bridge, London EC3N, 10 Pepys Street, London, EC3N 2NR
Event Timings:
18.00 | | Registration and coffee |
18.30 | | Presentations • Andrew Newland, CEO - Angle (AGL) • Jog Dhody, CFO - Regenersis (RGS) • Dr. Satu Vainikka, CEO - Valirx (VAL) + More to be announced |
20.30 | | Drinks reception and canapés |
21.30 | | Close |
Attendance is free, but spaces are limited.
Register now to secure your place!
Angle (AGL)
 | | ANGLE plc is a specialist medtech company listed on the London Stock Exchange AIM market (AGL.L). ANGLE's lead product is the Parsortix micro-fluidic cell separation device, which can capture very rare circulating tumour cells (CTCs) in cancer patient blood – even when there is less than one CTC in one billion healthy cells. ANGLE secured CE Mark regulatory authorisation for the clinical market in December 2013 and FDA authorisation work is in progress. The primary application is the capture of circulating tumour cells (CTCs) in patient blood for: · Early detection of cancer; · Personalised cancer treatment; · Monitoring of cancer patients during treatment; and · Post-treatment monitoring of cancer patients in remission. |
Regenersis (RGS)
 | | Regenersis is a leading, strategic outsourcing partner to the world’s premier consumer technology brands. Regenersis has built an increasingly global network of repair centres, delivered double digit revenue and profit growth, through cross-sell related services to major OEMs and network operators. In addition, the Group has traction with its scalable, high margin Advanced Solutions offering across the mobile and set top box markets. |
Valirx (VAL)
 | | Valirx Plc is an oncology-focussed Biopharmaceutical Company, developing treatments and diagnostics. Technologies are selected by using rigorous clinical and commercial processes to address unmet market needs. Clinical lead product is VAL201, a peptide for prostate cancer with follow-on indications in ovarian and breast cancers and endometriosis. Product VAL401, is a small molecule reformulation for lung cancers. The Company’s proprietary technology platform, GeneICE, enables selective silencing of rebellious genes’ inappropriate activity. VAL101, the first GeneICE therapeutic, targets and reduces expression of Bcl-2, implicated in about half of cancers. GeneICE extension to neurology and inflammatory diseases will follow. A novel diagnostic, the Nav3 system, detects pre-cancerous, cancerous and metastatic cells in tissue samples even before a tumour forms; indicating potential malignant formation. |
Sponsored by:
cp1
- 13 Jan 2016 08:50
- 180 of 183
This may well be worth another look with sterling coming off against the euro and falling significantly against the U.S dollar.
Once they sell the after service business then we are looking at a very fast growing pure software business. Certainly could fly if it can recapture 250p area and the sale goes to plan as this morning's rns seems to suggest.
cp1
- 08 Mar 2016 07:56
- 181 of 183
Excellent news. Now the pound isn't killing them, these look to have a very exciting growth business with Blancco. Should start to be re-rated very soon.
cp1
- 08 Mar 2016 09:25
- 182 of 183
Panmure BUY note 320p target.
cp1
- 15 Mar 2016 11:05
- 183 of 183
re-rating afoot....
Been over £4 last year and as I've stated before, the weak pound is very good for this one. Lots of upside to come here folks.